Featuring a large gantry aperture, the NewTom 7G is the most advanced CBCT device on the market. From in-depth detail to the big picture.
NewTom CBCT imaging now draws on fresh energy.
As of today NewTom 7G incorporates the Dual Energy (DE) system, elevating performance to new heights and revolutionising the way your practice operates.
Dual Energy: patented NewTom technology
The result of a continuous quest for patient well-being and ever-greater diagnostic precision, Dual Energy uses two different radiant energies to identify any pathologies with greater clarity and precision.
Virtual Monochromatic Images
Dual Energy technology mitigates beam-hardening artifacts. What’s more, being able to reconstruct monochromatic virtual images at different keVs improves soft tissue imaging quality and reduces metal artifacts. Lastly, Dual Energy CBCT provides a basis for tissue characterisation.
Colour-coded images
NewTom Dual Energy software enables users to perform semiautomatic tissue segmentation and apply colour codes, streamlining the differentiation of materials within the scanned area. This allows rapid and straightforward detection of potential pathologies.
Blended image
The new features enable weighted blending of high- and low-energy imaging. The resulting images combine the low noise, typical of highenergy acquisition, with the high contrast resolution of the low-energy image set.
BECAUSE HUMANITY IS THE GOAL... ACHIEVEMENTS IN HEALTHCARE ARE SHAPING THE FUTURE
Anyone observing the development of the healthcare sector in the Gulf region, particularly over the past decade, can see the extensive efforts made by both governments and the private sector to lead in this field, along with significant advancements in medical, technological, and administrative areas.
This remarkable progress highlights the contributions of leaders, CEOs, directors, and healthcare professionals. They have not only raised the standard of medical care and achieved what may seem miraculous, but they have also played vital roles in alleviating suffering, treating complex cases, and saving lives. In times of hardship, patients found support not only through faith but also in the expertise and dedication of these professionals.
Starting with strong principles and working with clear purpose yields abundant and impactful outcomes. In the Gulf region, the focus has consistently been on the well-being of individuals rather than solely on financial gains. This human-centered approach is the cornerstone of these achievements. Additionally, substantial investments have been directed toward human health, community welfare, and both physical and psychological security, resulting in healthcare institutions that meet global standards of quality and performance.
These accomplishments have been closely monitored and highlighted to keep the public informed about ongoing developments. HOSPITALS Magazine has proudly been among the first to share this message, tracking rapid advancements and acting as a true partner in delivering news, sharing insights, publishing updates, and spotlighting progress in the healthcare sector—both in the Arab world and especially in the Gulf region.
Today, hospitals offer hotel-like facilities, digital treatment methods, ecofriendly practices, and highly skilled professionals, all aimed at promoting a healthier, more prosperous life.
Let us continue to join hands, collaborate, and move forward toward even greater achievements!
The Publisher
Publisher Arab Health Media Communication
President Simon Chammas schammas@tahmag.com
Executive Vice President Mirna Khairallah mirna@tahmag.com
All rights reserved by the HOSPITALS magazine. No part of this publication can be reproduced in any form without prior permission in writting from the publisher.
24 Dr. Tarek Dufan, Chief Medical Officer, Chief of Excellence and Chief of Radiation Oncology at American Hospital Dubai
40 Clemenceau Medical Center-Beirut (CMC): A Global Leader in Smart Healthcare
60 UCLA Health: Novel Intraoperative Imaging Device Advances Precision Surgery for Patients with Cancer
Cedars-Sinai: Excellence in Healthcare
NEWS
38 BD Showcased Signature ProgrammesTM at Global Health
Saudi 2024, Emphasizing Commitment to Vision 2030 and Expanding Local Investments
50 Sysmex announces the official grand opening of Sysmex Saudi Regional Headquarter in Riyadh, Saudi Arabia
62 WCM-Q program promotes professionalism in medical education in a highly diverse culture
ARTICLES
48 Pharmaceutical Press shares effective practices for reducing medication errors
80 Testicular PRP: A New Hope for Treating Male Infertility Provided by Acibadem International
82 Why are more young people getting cancer? What to know as cases rise. Provided by UChicago Medicine
92 The Difference Between ICSI and IVF: Modern Medical Solutions for Delayed Pregnancy. Provided by Al Ahli Hospital-Qatar
98 How Can Insomnia Be Treated? Provided by Al Ahli Hospital-Qatar
100 The Delicate Balance of Patient Advocacy: Who Truly Has the Patient’s Best Interest in Mind? By Dr. Ali Elhaj
108 Electronic Cigarettes: A Modern Trend. Provided by Al Ahli Hospital-Qatar
INTERVIEWS
24 Dr. Tarek Dufan, Chief Medical Officer, Chief of Excellence
ACIBADEM International: How We Treat “Prostate Cancer”
and Chief of Radiation Oncology at American Hospital Dubai
58 Samih Al Mawass, Division Vice President for Abbott’s vascular business, EMEA
66 Dr. Rabih Maatouk, Plastic Surgeon in Abu Dhabi at Harley Street Medical Center
86 Mrs. Diana Boudargham Tannoury... A Survivor's Mission, President & Founder of Diana Boudargham Tannoury Women's Cancer Foundation
94 Dr. Edyta Skibinska, Assistant Professor of Hospital and Healthcare Management at American University in the Emirates
100 Renée-Marie Stephano, Global Healthcare Accreditation’s Chief Executive Officer
MEDICAL INSTITUTIONS
40 Clemenceau Medical Center-Beirut (CMC): A Global Leader in Smart Healthcare
56 Cedars-Sinai... Excellence in Healthcare
60 Novel Intraoperative Imaging Device Advances Precision Surgery for Patients with Cancer By UCLA Health
70 How We Treat “Prostate Cancer” and “Prostate Enlargement” At ACIBADEM
FEATURES
54 Revolutionizing Cancer Treatment:
74 Men’s Health Awareness Month
76 Protecting Prostate Gland
112 Transforming the Operating Room
Where
The World Health Organization (WHO) highlights the concerning prevalence of medication errors, estimating their global cost at $42 billion annually1.
MedicinesComplete supports organisations minimise medication errors with easy access to essential guidance, including information on prescribing, interactions, adverse effects, and administration.
1WHO. Medication Without Harm. 2022.[cited 25th April 2024]. Available from: Medication Without Harm (who.int)
ACIBADEM MOBIL
provides emergency and home care services outside of the hospital.
ACIBADEM APLUS
addresses the hygiene and catering requirements of the hospitals.
ACIBADEM HEALTH POINT ensures continuous support for patients from their arrival at Istanbul Airport until they return home, guiding them through their entire healthcare journey in Türkiye.
ACIBADEM TECHNOLOGY
develops and improves inhouse softwares including Hospital Information System and healthcare command center.
ACIBADEM UNIVERSITY
trains healthcare students to be future healthcare professionals.
ACIBADEM LABMED
offers a wide range of services including pathology, food control, stem cell and cord blood bank within the laboratory framework.
develops turnkey hospital establishment projects.
Unveiling ACIBADEM Healthcare Ecosystem
Step into a world where healthcare is not just a service, but a carefully designed ecosystem centered around Patient Safety and Patient Satisfaction – Welcome to ACIBADEM. At the forefront of innovative medical care, ACIBADEM's healthcare model is a testament to its unwavering commitment to excellence. Every facet of the healthcare journey is seamlessly integrated, with ACIBADEM collaborating with its supporting institutions at every step to mitigate risks and ensure service quality that aligns with ACIBADEM standards. Embark on a journey of cutting-edge medical services that transcend borders, as ACIBADEM extends its reach across Türkiye, Bulgaria, Macedonia, Serbia, and the Netherlands. Experience healthcare like never before, where your well-being takes center stage.
Excellence in Healthcare
Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024–25” rankings. As a global leader in healthcare, we offer a full range of services to patients from around the world. Whether we’re providing clinical services in your region via video visits or at our renowned medical center, our mission remains unchanged: to give patients access to excellence in healthcare—wherever they may be. Located in iconic Beverly Hills, Cedars-Sinai blends cutting-edge medicine in a vibrant setting known for its rich culture, famous landmarks and year-round warm weather—making it a leading destination for international patients seeking world-class treatment.
•
•
•
•
•
ESSENZA 300
Become a designer of a hospital bed
Patient comfort and well-being are getting more important within hospital care. The design of the room and the entire design concept can play a significant role in recovery.
Original Design
The Essenza 300 bed enables the integration of advanced medical beds into a unique hospital room concept due to SMART LINK technology. Thanks to SMART LINK you create the original design of bed ends and side rails.
Customized Solutions
Thanks to the unique technologies in LINET production can adapt the bed to your needs. We are ready to integrate colors and graphic motifs such as logos, photos, or other graphic elements.
Advanced Technology
Essenza 300 is a top-quality, smart hospital bed available as a universal low-height bed or Essenza 300 LT with bed-framed lateral tilt.
Jitka Stranska Managing Director of LINET MEA
“The fusion of hospital care and hotel services is increasingly evident. Prestigious hospitals not only pay attention to high-level medical standards but also to other aspects of hospitality, including, among others, top-quality interior design. We are delighted that our beds are once again bringing a new element: personalized room customization. Thanks to special technology, our new Essenza 300 bed offers a completely individual design to match the room concept or create pleasant healing environment.”
"Patients are at the heart of everything we do"
Dr. Tarek Dufan, Chief Medical Officer, Chief of Excellence and Chief of Radiation Oncology at American Hospital Dubai
The founding truth about medicine and its purpose was probably best captured by Hippocrates, who stated, "Wherever the art of medicine is loved, there is also a love for humanity." Providing healthcare is a humanitarian commitment, and American Hospital Dubai has honored this commitment for over 25 years. "Hospitals" magazine interviewed Dr. Tarek Dufan, the Chief Medical Officer, Chief of Excellence and Chief of Radiation Oncology at American Hospital Dubai, who shed light on American Hospital Dubai's role in providing the best possible healthcare.
The term' medical excellence' is common parlance in this era of healthcare evolution. It's a top catchphrase and a habituated aspiration for healthcare providers. But what does medical excellence mean?
Let's begin with the definition of excellenceit means greatness, the ability to achieve the very best in the field through excelling or being exceptionally good and possessing the most superior merit. But this is only the definition. For excellence to come alive and become a reality, it must be practiced – through implementation.
Achieving excellence in any field requires an understanding of purpose. What is your purpose?
In medicine and healthcare, the purpose is to treat and cure. But it is not such a simple aim; it is deeply nuanced. Your true purpose is to understand the person with the disease, not just the disease in the person. So, while treating and curing the disease is the primary objective, as is alleviating, reducing, and managing the distress and pain of discomfort due to the disease, it is about the person with the disease, not just the
disease alone, which means bringing empathy and an understanding of the psycho-social cultural nuances of patients that play a critical role in healing.
This understanding is the seed that births the concept of patient-centric care.
Everyone Deserves the Best Healthcare
Since its launch in 1996, American Hospital Dubai has ensured everyone receives the best quality healthcare. This conviction drives us. We believe healthcare must be progressive, inclusive, empathic, and all-encompassing.
American Hospital Dubai understands the macro vision that will result in the microobjective: patient satisfaction.
Patients are at the heart of everything we do. The term 'patient-centric' may seem obvious; healthcare is all about patients. However, implementing a genuinely patientcentric healthcare model is more complex than it appears. It involves many moving parts: Human Skills, Integrated Resources (Human and Technical), Policies, Workflows, Analytics, Vision, and Intent. Each component is non-dispensable and must be integrated seamlessly into a holistic process that delivers the best patient experience and treatment outcome.
Successful patient-centric care requires a multi-dimensional approach. You must do several things simultaneously with superior merit and intentional vigor. These include delivering the right kind of restorative care at the right time in the right way to ensure
WHILE TREATING AND CURING THE DISEASE IS THE PRIMARY OBJECTIVE, AS IS ALLEVIATING, REDUCING, AND MANAGING THE DISTRESS AND PAIN OF DISCOMFORT DUE TO THE DISEASE, IT IS ABOUT THE PERSON WITH THE DISEASE, NOT JUST THE DISEASE ALONE, WHICH MEANS BRINGING EMPATHY AND AN UNDERSTANDING OF THE PSYCHO-SOCIAL CULTURAL NUANCES OF PATIENTS THAT PLAY A CRITICAL ROLE IN HEALING.
patient satisfaction and well-being; promoting preventive and preservative health; staying abreast of the latest medical developments; investing in the best medical professional skills, infrastructure, and facilities and staff training and encompassing these disciplines with visionary leadership, mentoring, and empathy.
American Hospital Dubai adheres to these principles of continual achievement of medical excellence. We consciously construct the best possible healthcare model by investing in bestin-class physicians, specialists, and professionals with high-grade medical skills and experience. We integrate human skills with AI and Big Data to give our patients the best chance at receiving life-changing treatments. We practice interoperability in disease treatment and care, choose evidence-based solutions, keep abreast of evolving treatment methodologies, and integrate innovation and research-led breakthroughs in care delivery.
We are committed to sustainability and guided by exemplary leadership, which helps us deliver benchmark healthcare in the UAE and the region year after year.
But there's more to excellent patient care: medical expertise and know-how. These gamechangers make the difference when a patient seeks the best medical treatment.
Why We Prefer To Be The Change We Seek For The World
American Hospital Dubai believes in being the change we desire for humanity, so we established our centers of excellence and dedicated advanced units in critical medical fields. We harnessed our expertise and experience to set up our leading-edge hubs of treatment centers that are the regional leaders in their respective fields, offering state-of-theart procedures and surgeries.
Our Heart & Vascular Center, Diabetes Center, Orthopedics (Total Joints Replacement Center), Cancer Care Center, and Center of Excellence in Robotic Surgery (COERS) are the region's leading hubs for advanced treatments and cutting-edge solutions for complex diseases. Our dedicated units include a Breast Care Clinic, Prostate Clinic, Hernia
Center, Physiotherapy and Rehabilitation Center, Dialysis Unit, American Children Center Dental Clinic, and the Stem Cell Unit (Bone Marrow Transplant Unit), Dubai's first and only autologous hematopoietic stem cell/bone marrow transplant facility.
American Hospital Dubai's synergy with the UAE's government's National Strategy for Artificial Intelligence (AI) 2031 led us to take a head start with AI, Big Data and Digitization, integrating them into our innovation-led treatment solutions and work processes. We set up the region's first AI-led research center in Dubai in collaboration with medical technology giant Cerner in 2020. This year, we launched The Face, the region's most advanced skincare and plastic surgery destination, offering the latest solutions and services in dermatology and aesthetics. It combines world-class medical expertise, advanced technology, and commitment to patient-centric care.
We have always committed to a keen understanding of the client's emotional value of decision-making. The Face will deliver on it in the highly sought-after area of skin care treatments and plastic surgery procedures.
Shaping Dubai's Robotic Surgery Era and Leading in Complex Disease Treatment
Staying relevant in a rapidly evolving healthcare scenario matters not because you need to stay in the game but because your role is to help patients benefit from the latest medical developments.
Robotic surgery advances have transformed healthcare. We are proud to be the first medical facility in the UAE to fully explore its advantages, earning us a leading place in Dubai's robotic surgery era.
Our Center of Excellence in Robotic Surgery (COERS) is the first private healthcare facility in the region to earn accreditation from the USbased Surgical Review Corporation (SRC).
American Hospital Dubai was the first private healthcare provider in the UAE to install the 4th generation DaVinci Robotic System and the ROSA® Knee System. We are also the first private medical facility in Dubai to install the Halcyon® system radiation therapy and the
WE INTEGRATE HUMAN SKILLS WITH AI AND BIG DATA TO GIVE OUR PATIENTS THE BEST CHANCE AT RECEIVING LIFE-CHANGING TREATMENTS. WE PRACTICE INTEROPERABILITY IN DISEASE TREATMENT AND CARE, CHOOSE EVIDENCE-BASED SOLUTIONS, KEEP ABREAST OF EVOLVING TREATMENT METHODOLOGIES, AND INTEGRATE INNOVATION AND RESEARCH-LED BREAKTHROUGHS IN CARE DELIVERY.
Mazor X Stealth™ edition Robotic Guidance System for spinal surgeries.
We have conducted over 1,500 robotic surgeries since 2020, when we launched this unit, and our expertise in adult and pediatric robotic surgeries has set several milestones. These accomplishments demonstrate our ability to deliver superior patient experiences continually because that commitment drives our use of advanced procedures.
Our leadership in complex disease treatments and surgeries is driven by a commitment to addressing the crucial need to find solutions for challenging diseases. Complex disease treatment requires highgrade expertise, dedicated resources, and a commitment beyond the traditional boundaries of care management.
Pursuing this vision means initiating our own best practices, and our specialized
complex disease treatment hubs have helped us blaze a trail in complex disease management innovations. American Hospital Dubai has achieved several firsts and set many milestones in complex treatments and surgeries, including robotics. To give a few examples of exceptional breakthroughs this year alone, we performed the region's first robotic pediatric surgery, a Right Diaphragmatic Hernia, on an infant to treat Congenital Diaphragmatic Hernia (CDH), a rare condition in newborns.
We are proud to have performed Dubai's first-ever robot-assisted Whipple procedure, a modified PPPD or Pylorus Preserving
OUR LEADERSHIP IN COMPLEX DISEASE TREATMENTS AND SURGERIES IS DRIVEN BY A COMMITMENT TO ADDRESSING THE CRUCIAL NEED TO FIND SOLUTIONS FOR CHALLENGING DISEASES.
Pancreaticoduodenectomy (PPPD,) to remove a tumor at the head of the pancreas.
We achieved a breakthrough in a highly complex and rare neurological case of Acute Disseminated Encephalomyelitis, or ADEM, in a female patient who had previously sought treatment elsewhere without success.
We helped her regain her ability to walk with a cane, communicate verbally, be free of the tracheostomy, feed herself, and eat a regular diet. Our exceptional expertise in open surgeries was evidenced in an open aorto-bifemoral bypass with graft and thrombectomy of the aorta and renal arteries on a 53-year-old male patient with cardiac and peripheral artery disease. It is a highly complex surgery and was among the region's milestone achievements.
We performed a highly complex lung surgery on a 15-day-old infant with Congenital Lobar Emphysema, a rare condition that went misdiagnosed and untreated till the parents brought the baby to us.
The Role of Conscious Choices in Pursuing Excellence
American Hospital Dubai has an intentionally designed patient-centric healthcare model, which we believe is essential to leadership performance. We make conscious choices in designing our performance and care delivery to go beyond the conventional disease-andtreatment boundaries and function in an innovation-led, pioneering territory.
Our clinical decisions and actions are patient-centered; we continually enhance our knowledge through experience and promote and share our knowledge through education and training.
We undertake continual reviews of our performance and goals and have implemented the Service Excellence Program to ensure the highest standards of care. It is intrinsic to our pursuit of excellence and drives us to improve our performance consistently. We have a Clinical Education Department offering multidisciplinary education programs for clinical staff to keep up the momentum. We shape our policies and work processes to align with our commitment to patient satisfaction. Earlier this year, we
remodeled our Human Resources Department into the People Innovation and Impact Department. The transformative initiative will nurture human endeavor through the selfdetermination of work value and contribution to collaborative progress, further consolidating American Hospital Dubai's organizational culture of excellence and people empowerment through innovation.
Expanding Our Medical Care Excellence Footprint in UAE and Globally
In 2024, American Hospital Dubai expanded its footprint by opening a multispecialty hospital in Dubai Science Park, Al Barsha South. The American Hospital Dubai Science Park is a strategic move to demonstrate further our commitment to bringing world-class healthcare to more people.
American Hospital Dubai Science Park is home to the region's most advanced brain suite, an advanced and comprehensive cancer center, and trauma care. It has state-of-theart facilities and expertise in over 20 medical fields including Orthopedics, Rheumatology, Neurosurgery, Pediatrics, ENT, Breast Surgery, Ob/GYN, General Surgery, Plastic Surgery, Urology, Dermatology, Neurology, Primary Care, Gastroenterology, Nephrology, Endocrinology, Ophthalmology, Cardiology, Pulmonology, Radiation Oncology, Radiotherapy, NICU and PCC. It is in addition to our seven dedicated clinics across Dubai in Dubai Media City, Al Barsha, Al Khawaneej, Jumeirah, Mira, Dubai Hills, and Nad Al Sheba to make world-class medical care more accessible to people.
We are also active partners in promoting Dubai's medical tourism goals. We aim to create a synergy between Dubai's excellent medical facilities and fulfill the expectations of international patients seeking the best solutions for their health recovery.
American Hospital opened its first medical
AMERICAN HOSPITAL DUBAI SCIENCE PARK IS HOME TO THE REGION'S MOST ADVANCED BRAIN SUITE, AN ADVANCED AND COMPREHENSIVE CANCER CENTER, AND TRAUMA CARE. IT HAS STATE-OFTHE-ART FACILITIES AND EXPERTISE IN OVER 20 MEDICAL FIELDS INCLUDING ORTHOPEDICS, RHEUMATOLOGY, NEUROSURGERY, PEDIATRICS, ENT, BREAST SURGERY, OB/GYN, GENERAL SURGERY, PLASTIC SURGERY, UROLOGY, DERMATOLOGY, NEUROLOGY, PRIMARY CARE, GASTROENTEROLOGY, NEPHROLOGY, ENDOCRINOLOGY, OPHTHALMOLOGY, CARDIOLOGY, PULMONOLOGY, RADIATION ONCOLOGY, RADIOTHERAPY, NICU AND PCC.
representative office in Lagos, Nigeria, as part of its 30-office expansion across Africa and Eastern Europe. The Lagos office will promote local community engagements and knowledgesharing online seminars with Nigerian healthcare professionals and address the needs of more Nigerians looking for affordable and trusted healthcare overseas.
Healthcare Leadership Requires a 360° Vision
Among the hallowed ideals of leadership is legacy building. Healthcare is intrinsic to progress, and its role in improving the human condition is forever reshaped by time, discoveries, improvements, challenges, enquiry and search for better solutions. American Hospital Dubai integrates with these forces of change through diverse approaches: innovation, education, research, AI and Big Data, and progressive partnerships with the finest medical institutions globally. We believe these assets enhance our patient-centric delivery model.
We launched the American Hospital Academic Institute (AHAI) to train healthcare professionals and develop talented staff in the UAE and the region. AHAI, in partnership with Robotics Surgical Systems (RSS) and UK-based CMR Surgical, set up the first robotic surgical training hub for MEA in Dubai to promote expertise sharing through training and education to boost medical professionalism in the region. The more we widen the pool of skilled resources, the better we can serve patients.
Our decision to partner with the prestigious Baylor College of Medicine (BCM), Texas, US, to set up a full-fledged medical college and campus on American Hospital premises in Dubai further proves how our education ideology drives us. Baylor College of Medicine is a medical school and research center within the Texas Medical Center, the world's largest medical center. The medical college in Dubai will offer the BCM curriculum, bringing world-class know-how and skills to the UAE and the region. The partnership is a milestone project for the region's healthcare landscape, reaffirming American Hospital Dubai's pledge to promote medical education and raise healthcare standards.
Building Healthier Tomorrow Is Unconditional Responsibility
The finest medical institutions and healthcare providers have a common goal: establishing a continuum of excellence to benefit people and empower them to lead healthier, happier lives. In other words, it is legacy building. American Hospital Dubai's mission and vision are to continuously learn and update knowledge, performance, and skills and embrace innovation and breakthroughs to deliver on its promise of world-class patient-centric care. We subject ourselves daily to fundamental self-scrutiny: What are we here for, what do we want to achieve, and for whom? How can we do it better than yesterday? These impetuses drive us to pursue exceptional outcomes continually. We believe progress by self-scrutiny is the best tool to shape the future we want.
AHAI, IN PARTNERSHIP WITH ROBOTICS SURGICAL SYSTEMS (RSS) AND UK-BASED CMR SURGICAL, SET UP THE FIRST ROBOTIC SURGICAL TRAINING HUB FOR MEA IN DUBAI TO PROMOTE EXPERTISE SHARING THROUGH TRAINING AND EDUCATION TO BOOST MEDICAL PROFESSIONALISM IN THE REGION.
NUPCO Enhances Private Sector Engagement With New MoUs During
its Participation in Global Health Exhibition 2024
The National Unified Procurement Company (NUPCO), Saudi Arabia’s leading procurement and logistics company for healthcare supplies, has successfully concluded its participation as a Foundation Partner in the Global Health Exhibition 2024. Alongside contributing to strategic discussions on the future of healthcare investment and innovation, NUPCO took further steps to expand into the private sector with 10 new Memoranda of Understanding (MoUs), in addition to agreements securing insulin supplies for the Kingdom and the region.
NUPCO’s CEO Fahad Al Shebel said: “Our participation in the Global Health Exhibition 2024 underscores NUPCO’s commitment to driving innovation in healthcare logistics. Through new agreements with global biopharmaceutical leaders Novo Nordisk and Sanofi, we are taking a major step in localizing the production of insulin, which is vital to Saudi Arabia and international markets. These partnerships not only enhance healthcare efficiency but also align with Vision 2030’s goals of creating a more resilient and selfsufficient healthcare ecosystem.”
NUPCO signed over 15 new MoUs at the event, including 10 with the private sector. These complement the two additional partnerships signed with Novo Nordisk and Sanofi to localize the manufacture of insulin in the Kingdom, contributing to the resilience of Saudi Arabia’s healthcare supply chain, broadening patient access, and driving national economic diversification. NUPCO’s agreements are part of its commitment to strengthening public and private sector partnerships and collaboration in areas including innovation, operational efficiency, and sustainability.
NUPCO also hosted a hackathon at the event in collaboration with the Ministry of Health, the Health Holding Company, and the National Center for Promoting Mental Health. Bringing together more than 500 teams of
innovators from both Saudi Arabia and abroad, the Hackathon spurred innovative solutions to tackle six proposed mental health challenges in the workplace, at home, and across society. During the Hackathon closing ceremony, which featured speeches by His Excellency Fahad bin Abdurrahman Al-Jalajel, Saudi Minister of Health, and by the NUPCO CEO, the five winning teams received awards from the prize pool of SAR100,000.
The Global Health Exhibition 2024 is a strategic platform for over 100,000 healthcare professionals, policymakers, and industry leaders from 40 countries to engage in healthcare policy, innovation, and investment. Senior NUPCO executives, including NUPCO’s CEO, contributed their insights across multiple panel discussions, sharing their expertise on the future of healthcare logistics.
Founded in 2009, NUPCO is wholly owned by the PIF. It operates in the field of providing medical procurement, storage, and distribution services for pharmaceuticals, medical devices, and medical supplies in Saudi Arabia.
NUPCO SIGNS OVER 15 NEW MOUS AT THE GLOBAL HEALTH EXHIBITION 2024, DEEPENING ITS TIES WITH THE PRIVATE SECTOR AND ADVANCING COLLABORATION WITHIN THE PUBLIC SECTOR
T he Uni ve r si t y o f
u t o t he F o r ef r on t
Where some of the greatest advances in medicine are hard at work for you. The University of Chicago Medicine pioneers the kind of research that’s changing lives. It is home to the most advanced medical technology, and physicians who work at the forefront of their fields.
It is our mission to bring the forefront of medicine to the world through personalized international patient services and tailored global advisory and education programs.
Clinical Centers of Excellence
» Comprehensive Cancer Center
» Transplant Institute
» Heart & Vascular Center
» Neuroscience Center
» Digestive Diseases Center
» Orthopaedic Surgery
» Obstetrics & Gynecology
» Pediatrics
For more information, visit UChicagoMedicine.org/global
100 Nobel L aureates, including 12 in Physiology or M edicine Magnet Recognition for E xcellence in N ursing & Patient C are
O ne of only 15 acute - c are facilities nationwide to receive “A” grade in patient safet y f rom Leapf rog G roup for 25 consecutive periods as of M ay 202 4
Ranked nationally in multiple adult and children’s specialties by U S N ews & World R epor t
World-Class Innovations in Robotic Surgery, Organ Transplantation, and Personalized Medicine
KFSHRC Unveiled Pioneering Medical Advancements
King Faisal Specialist Hospital & Research Centre (KFSHRC), a leading healthcare institution in the Middle East, was a Platinum Sponsor of Global Health Exhibition 2024 in Riyadh.
KFSHRC unveiled its latest advancements in healthcare, highlighting their impact on improving patient outcomes, experience, and operational efficiency.
These innovations include:
• The launch of the Mobile Stroke Unit aims to expedite stroke treatment and save lives.
• Robotic heart surgery and the world's first complete robotic heart transplant.
• Organ transplantation programs.
• Pioneering CAR-T cell production, a significant enhancement for specialized care in the Kingdom.
• Pharmacogenomic analysis, a personalized medicine approach tailoring medications to a patient's DNA.
• The innovative capacity command center for optimized hospital operations.
• Groundbreaking use of virtual reality in medical education.
King Faisal Specialist Hospital & Research Centre's participation underscores its dedication to exploring modern healthcare trends, anticipating the future of the field, and solidifying its position as a global healthcare innovator. Visitors to the pavilion gained insights into the hospital’s groundbreaking achievements. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, Newsweek magazine ranked it among the world's best 250 hospitals and included it in the World’s Best Smart Hospitals for 2025.
IT IS NOTEWORTHY THAT KFSHRC HAS BEEN RANKED FIRST IN THE MIDDLE EAST AND AFRICA AND 20TH GLOBALLY IN THE LIST OF THE WORLD’S TOP 250 ACADEMIC MEDICAL CENTRES FOR THE SECOND CONSECUTIVE YEAR AND HAS BEEN RECOGNIZED AS THE MOST VALUABLE HEALTHCARE BRAND IN THE KINGDOM AND THE MIDDLE EAST, ACCORDING TO THE 2024 BRAND FINANCE RANKINGS.
Cancer treatment plans built around you.
Our experts get to know you, then tailor treatments to help fit your needs—which could include radiation, surgery, chemotherapy, immunotherapy, cellular therapy, genetic counseling, or a customized lifestyle management plan. In collaboration with Baylor College of Medicine, we’re equipped to pave the way for even more revolutionary discoveries and groundbreaking approaches to cancer prevention, diagnosis, and treatment.
Learn more about the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine at stlukeshealth.org/bslmcinternational
M42’s ADHDS Partners with US-based Amaze Health to Drive International Expansion
During GITEX 2024, M42’s Abu Dhabi Health Data Services (ADHDS), a premier digital healthcare solutions company, signed a Memorandum of Understanding (MoU) with Amaze Health, a global virtual medical care technology company. The partnership will leverage the complementary strengths of both organizations to explore investment opportunities, expand into new markets, and develop innovative digital health solutions. The MoU was signed by Kareem Shahin, CEO of M42’s Abu Dhabi Health Data Services and David Silverstein, CEO of Amaze. This collaboration aligns with Abu Dhabi's ambitious vision to become a global healthcare hub and underscores ADHDS' commitment to delivering world-class healthcare services.
Kareem Shahin, CEO of M42’s Abu Dhabi Health Data Services (Malaffi), commented, "We are thrilled to partner with Amaze to explore the vast potential of digital health in transforming healthcare delivery globally. By combining our expertise and resources, we can create innovative solutions that improve patient outcomes and drive sustainable growth."
David Silverstein, CEO of Amaze, added, "This partnership represents a significant milestone for Amaze Health as we expand our global footprint and collaborate with a leading healthcare technology company like ADHDS. We are excited to explore opportunities for investment, market expansion, and joint product development."
As part it’s international growth strategy, ADHDS will explore an investment in Amaze, with both parties engaging in discussions about the desired percentage of shareholding and value-added contributions. ADHDS and Amaze will collaborate to introduce Amaze’s products and services to markets outside the US, including the UAE, GCC Countries, North Africa, and Europe, leveraging ADHDS's expertise and reach. Both parties will explore opportunities to introduce ADHDS's innovative digital health solutions to the US market through the Amaze Health partnership. By working together, ADHDS and Amaze aim to create a mutually beneficial partnership that drives revenue growth, enhances healthcare delivery, and positions Abu Dhabi as a global leader in healthcare innovation.
ADHDS AND AMAZE WILL COLLABORATE TO INTRODUCE AMAZE’S PRODUCTS AND SERVICES TO MARKETS OUTSIDE THE US, INCLUDING THE UAE, GCC COUNTRIES, NORTH AFRICA, AND EUROPE, LEVERAGING ADHDS'S EXPERTISE AND REACH.
BD Showcased Signature ProgrammesTM at Global Health Saudi 2024, Emphasizing Commitment to Vision 2030
and Expanding Local Investments
The Saudi entity of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, participated at the Global Health Exhibition in Riyadh, Saudi Arabia, from 2123 October, 2024. In its second consecutive year of participation, BD spotlighted its latest Signature ProgrammesTM focused on Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency.
The BD booth (H2B-R10) served as a hub for healthcare professionals, partners, and key stakeholders to explore the transformative impact of the company’s innovative solutions. With a primary focus on improving healthcare outcomes, BD’s solutions span the continuum of care, from diagnostics to medication management, infection prevention, and beyond.
“As a committed partner to Saudi Arabia’s healthcare transformation, BD was proud to participate in Global Health Saudi 2024 and highlight our ongoing efforts to promote patient safety, protect healthcare workers, and drive operational efficiencies,” said Omar Malabarey, Country General Manager for BD in Saudi Arabia. “We were eager to showcase our Signature ProgrammesTM and innovative
solutions that address the evolving needs of healthcare professionals and patients while continuing to invest in the Kingdom’s healthcare landscape through local presence, education, and innovation.”
In line with Saudi Arabia's Vision 2030, BD continues to strengthen its commitment to the Kingdom’s healthcare system through local investments and partnerships. Following the successful launch of its regional headquarters in Riyadh in 2023, and in line with its efforts to support the Kingdom’s efforts in developing a world-class healthcare infrastructure, BD is further deepening its presence in the country with plans to open a Training and Education Academy in 2024. This Academy will be a vital platform to enhance the skills of healthcare professionals across the country by offering clinical and technical hands-on training sessions, and thereby improving patient safety and care delivery outcomes. In addition to unveiling its plans for the Academy, BD will also provide insights into its recent acquisition of Edward Life Sciences, which further bolsters the company’s patient monitoring portfolio and enhances its capabilities in delivering integrated healthcare solutions in the Kingdom.
COMPANY
HIGHLIGHTED THE INNOVATIVE SOLUTIONS ALIGNED WITH ITS SIGNATURE PROGRAMMESTM; EMPHASIZES COMMITMENT TO ADVANCING THE KINGDOM’S VISION 2030 WITH CONTINUED EXPANSION AND INVESTMENTS.
Clemenceau Medical Center-Beirut (CMC) A Global Leader in Smart Healthcare
Clemenceau Medical Center-Beirut (CMC) is proud to announce its recognition as one of the world’s best smart hospitals by Newsweek and Statista, marking its third consecutive time as the only hospital listed in Lebanon. This achievement highlights CMC's commitment to integrating advanced technologies in healthcare, including Artificial Intelligence, Robotic Surgery, Digital Imaging, and Telemedicine.
With state-of-the-art facilities and a robust IT infrastructure, CMC continues to provide innovative, patient-centered care. Lebanon, known as the "Middle East Hospital", boasts a healthcare sector that ranks among the best in the world, continually evolving in medical services. The country achieves significant successes and quality milestones, showcasing its ability to face challenges and overcome obstacles in the current healthcare landscape.
CMC proudly holds its place among the best, having been recognized by Newsweek for the third time as the standout hospital in Lebanon and one of the leading hospitals in the Middle
East. This recognition reflects its excellence compared to major healthcare institutions in the U.S., Europe, and the Arab world.
Furthermore, CMC enhances Lebanon's position on the global medical map by utilizing innovative technologies that provide new treatment and comprehensive care options for both Lebanese patients and those coming from abroad exclusively for treatment.
CMC is committed to continuous improvement and innovation in healthcare through ongoing investments in state-of-the-art medical equipment and the latest technologies. The advanced diagnostic tools, enhanced by artificial intelligence, offer unprecedented accuracy and efficiency.
Despite the current circumstances and challenges, Lebanon remains resilient and committed to progress. CMC remains at the forefront of medical innovation, delivering advanced healthcare services that ensure the highest quality for patients. These ranking underscores Lebanon's potential for excellence in medical care, affirming that the healthcare sector is a beacon of hope and progress.
Liquid biopsy in breast cancer – Less invasion more precision
Plasma-SeqSensei™
Liquid biopsy in breast cancer – Less invasion more precision
Plasma-SeqSensei™
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
Learn more about the unique advantages of Plasma-SeqSensei technology
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
High sensitivity at low MAFs
Learn more about the unique advantages of Plasma-SeqSensei technology
Down to 0.06% - 0.07% Mutant Allele Fractions.
High sensitivity at low MAFs
Down to 0.06% - 0.07% Mutant Allele Fractions.
Absolute quantification
Short and standardised workflow
From cfDNA samples to results in two days.
Short and standardised workflow
From cfDNA samples to results in two days.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Absolute quantification
Meaningful comparison of ctDNA levels per millilitre of plasma.
Expert voices
Meaningful comparison of ctDNA levels per millilitre of plasma.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Expert voices
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
‘There is much more diagnostic power in the absolute quantification.’
Dr Bhuwnesh Agrawal Member of The Supervisory Board Sysmex Inostics and MD, Germany
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
Dr Bhuwnesh Agrawal Member of The Supervisory Board
Sysmex Inostics and MD, Germany
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
‘There is much more diagnostic power in the absolute quantification.’
Prof. Christopher Gebhardt UKE Hamburg, Germany
Prof. Christopher Gebhardt
UKE Hamburg, Germany
Prof. Geert A. Martens AZ Delta General Hospital, Belgium
Prof. Geert A. Martens AZ Delta General Hospital, Belgium
The Department of Health – Abu Dhabi and Accenture Collaborate to Drive Digital Transformation Across the Healthcare Sector
The Department of Health – Abu Dhabi (DoH) the regulator of the healthcare sector in the Emirate of Abu Dhabi, signed a Memorandum of Understanding (MoU) with Accenture, a leading global professional services company. Through this strategic partnership, the parties aim to further solidify health data governance, elevate healthcare services and enhance patient outcomes in the Emirate through leveraging Accenture’s advanced data and AI solutions and global expertise.
DoH and Accenture seek to harness the power of technology and cutting-edge innovations to drive significant advancements in the healthcare sector, with an emphasis on Data Governance Execution, Health AI Use Case Advisory and Health Data Infrastructure. Further reinforcing DoH’s commitment to building a resilient and innovative sector that is increasingly data-driven and technologically advanced. In the presence of HE Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health –Abu Dhabi (DoH), the MoU was signed by Ibrahim Al Jallaf, Executive Director of Digital Health at DoH and and Nadya Abdulla Kamali, UAE Country Managing Director of Accenture.
Ibrahim Al Jallaf, Executive Director of Digital Health at the Department of Health – Abu Dhabi (DoH), said: “The Department of Health – Abu Dhabi (DoH) is delighted to be working alongside our esteemed partners at Accenture. This partnership marks a significant step in our journey towards elevating the sector’s digital healthcare outcomes in Abu Dhabi. Through leveraging advanced data analytics and AI, we are committed to delivering personalised and efficient care to our community members. Together with Accenture, we aim to optimise resource allocation and empower healthcare professionals and providers to enhance their processes, ensuring our healthcare ecosystem remains agile, innovative, and prepared for future challenges. This collaboration underscores our commitment to developing a future-ready ecosystem that prioritises patient
outcomes and employs predictive analytics for early intervention, further solidifying the Emirate's position as a leading healthcare destination globally.”
Nadya Abdulla Kamali, UAE’s Country Managing Director at Accenture, added: “In Accenture, we are committed to supporting the UAE’s vision in building a world-class, technologydriven healthcare system. By combining our global healthcare expertise in both advanced Data and AI capabilities and patient experience, we can help the Department of Health - Abu Dhabi achieve its goal of creating a more efficient, patient-centric, and sustainable healthcare ecosystem. Our focus on innovation ensures that we are not only more responsive but also proactive in meeting the evolving needs of community members, delivering long-term value and improved well-being for all residents in the UAE.”
DOH AND ACCENTURE WILL WORK HAND IN HAND TO IMPLEMENT ROBUST DATA GOVERNANCE POLICIES AND PROCESSES TO ENSURE EFFECTIVE DATA MANAGEMENT AND MONITORING, ADHERING TO THE HIGHEST QUALITY STANDARDS ACROSS THE SECTOR.
Empower Your Practice: Continuous Learning for Lifelong Care!
Advance your practice with Weill Cornell Medicine-Qatar’s Continuing Professional Development (CPD) division! Our accredited programs are recognized locally by the Department of Healthcare Professions (DHP) of the Ministry of Public Health (MoPH) and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
Stay informed in the dynamic healthcare landscape through our expert-led workshops and seminars designed to deepen your knowledge and empower you to deliver exceptional patient care.
Ready to invest in your professional development?
Register today and make a difference in patient care!
Browse our website and stay connected on social media!
cpdweillcornellmedicine-Qatar
cpd.weillcornellqatar
cpdweillcornellmedicine-Qatar
Lean Business Services Showcases Groundbreaking AI-Powered Innovations
and Strategic Partnerships
Lean Business Services (Lean) has successfully showcased its latest suite of healthcare innovations at the Global Health Exhibition (GHE), reinforcing its pivotal role in Saudi Arabia’s healthcare transformation. With a focus on AI-powered solutions, these innovations are designed to enhance efficiency, accuracy, and patient care, align with Vision 2030 and the Health Transformation Program, driving the Kingdom’s digitalization efforts forward.
As a leader in healthcare technology, Lean is pioneering the development of integrated digital solutions that empower healthcare providers to deliver more accurate, efficient, and patient-centered care. These solutions, developed in close collaboration with key stakeholders, represent a major step toward transforming Saudi Arabia’s healthcare ecosystem.
Strategic Partnerships for a Unified Health System and Expanding Health Services in the Private Sector
At GHE 2024, Lean cemented its role as a key partner in the Kingdom's healthcare transformation by signing a number of strategic agreements. These include a landmark agreement with the Ministry of Health to develop a unified health file for primary healthcare centers, aimed at improving the quality of services and standardizing performance measures across the system.
Further strengthening its position in the private sector, Lean signed an MoU with Tuwaiq Medical to expand its Raqeem service. Raqeem is a comprehensive health information system (HIS), is designed to record patients' medical data and improve the experience for healthcare practitioners. It is fully compatible with the Unified Health Record (Nphies) and can be seamlessly integrated with external hospital systems, offering a robust solution for managing patient medical records and bringing advanced digital health solutions to a wider audience. Additionally, Lean entered
a partnership with Enigma Genomics, which will leverage the power of AI and genomics to deliver personalized healthcare tailored to the needs of individual patients.
Transforming Clinical Coding with the Tarmeez Platform
Lean also unveiled the Tarmeez platform, a comprehensive solution covering the entire medical coding process. Tarmeez assists in obtaining medical notes, classifying hospitalization costs, and determining the cost of services. It also features an audit component, ensuring accuracy and accountability throughout the entire coding process. This platform is a game-changer for hospitals and healthcare providers, improving the management of medical records and financial reporting.
"Our solutions not only empower providers to deliver more efficient and patient-centered care, but they also align with Saudi Arabia’s healthcare vision, enabling us to contribute meaningfully to the nation’s health goals” further stated Mohanned Al Rasheed, CEO of Lean Business Services.
DOH AND ACCENTURE WILL WORK HAND IN HAND TO IMPLEMENT ROBUST DATA GOVERNANCE POLICIES AND PROCESSES TO ENSURE EFFECTIVE DATA MANAGEMENT AND MONITORING, ADHERING TO THE HIGHEST QUALITY STANDARDS ACROSS THE SECTOR.
Your Trusted Your Trusted Healthcare Healthcare Partner Partner
Guided by a passion for health and wellness, we bring reliable products to healthcare providers everywhere Let’s create a world where quality healthcare is a reality for all
GE
HealthCare and Hayat National Hospitals enter a partnership to fuel healthcare expansion across Saudi Arabia
GE HealthCare (Nasdaq: GEHC), a leading global medical technology and digital solutions innovator, has announced a multi-modality partnership with Hayat National Hospitals, marking a substantial investment in healthcare infrastructure and equipment across Saudi Arabia.
Announced at the 2024 Global Health Exhibition, GE HealthCare’s groundbreaking collaboration with the renowned Saudi-based private hospital group will equip three new Hayat National Hospitals in Muhayl Aseer, Baysh, and Buraida with advanced diagnostic imaging technologies. The initiative aims to significantly improve healthcare access and services for residents in these regions, underscoring both organizations' commitment to enhancing healthcare infrastructure and patient outcomes in the Kingdom.
The deal will provide Hayat National Hospitals with a comprehensive suite of medical imaging solutions, including GE Healthcare's first SIGNA™ Victor system in Saudi Arabia that harnesses the power of deep learning to deliver exceptional image quality, enhance patient comfort, and reduce costs. Hayat National Hospitals will leverage these advanced technologies as they expand their reach with 3,000 total bed capacity to ensure wider access to quality healthcare in the Kingdom. The strategic partnership will further accelerate the ongoing growth and transformation of Saudi Arabia’s healthcare sector, aligning with the Kingdom’s Vision 2030 goals.
Saudi Arabia has positioned healthcare at the forefront of its national priorities, demonstrating its commitment with a USD 65 billion investment in the Kingdom’s healthcare infrastructure, which accounts for 60 percent of the total healthcare spending across all Gulf Cooperation Council (GCC) countries.
Dr. Fouziyah AlJarallah, Group CEO - Hayat National Hospitals, said: “Embracing cuttingedge technology is central to our vision of redefining healthcare in Saudi Arabia. The
strategic partnership with GE HealthCare empowers us to harness the power of innovative imaging solutions across the three new hospitals in our portfolio. This collaboration is a key driver in our expansion strategy, enabling us to make world-class healthcare accessible to even more communities and build a more robust healthcare ecosystem across the Kingdom.”
Mohammad Elkhoury, General Manager for GE HealthCare for Middle East, added: “Our partnership with Hayat National Hospitals represents a significant investment in the future of healthcare in Saudi Arabia, reflecting our shared vision of delivering world-class healthcare solutions that are accessible, affordable, and of high quality. The strategic investment, aligning with the Vision 2030 agenda, will empower healthcare professionals at Hayat National Hospitals to deliver faster, more precise diagnoses and treatment plans across a wide range of medical specialties, ultimately leading to enhanced patient care.”
This collaboration between GE Healthcare and Hayat National Hospitals represents a major step forward in delivering healthcare improvements and strengthening the health landscape in KSA.
BY FOSTERING STRATEGIC PARTNERSHIPS TO LEVERAGE INNOVATIVE TECHNOLOGIES THAT STREAMLINE THE WORKFLOW AND ENABLE CLINICIANS TO MAKE FASTER AND MORE ACCURATE DIAGNOSES, BOTH ORGANIZATIONS DIRECTLY SUPPORT SAUDI ARABIA'S HEALTHCARE TRANSFORMATION GOALS AND REMAIN COMMITTED TO ADDRESSING THE KINGDOM’S EVOLVING HEALTHCARE NEEDS
Pharmaceutical Press shares effective practices for reducing medication errors
Medicines are the most common therapeutic intervention in healthcare, and they have now become much more complex. Although patients benefit considerably as a result of living longer and better-quality lives, many experience significant harm due to mistakes or errors in how medicines are used. Medication errors occur frequently in health systems around the world, and, according to the World Health Organization (WHO), nearly 50% of preventable harm to patients globally is due to inappropriate use of medicines and other treatments. A quarter of this preventable harm can be severe or even life-threatening.1,2 Even when errors are not harmful or severe, they can drive the cost of care up, and the quality of care down.1 Fortunately, with greater awareness of the scale of the problem, there is now a focus on ensuring a culture of safety in health systems. With the right education, policies, prescribing tools, and reporting and learning systems, errors can be minimized and patients protected.
What are the most common types of medication errors?
Most studies refer to five main types of error, namely those related to prescribing, transcribing, preparation or dispensing, administration, or monitoring. Aronson also noted that errors could occur during the medicine manufacturing process, for example, when the packaging is incorrectly labeled, or adulterants are introduced.3
Preventing medication errors
Medication errors are a multifaceted problem, there is no one size fits all solution. Rather, tailored approaches to understanding and mitigating the risks are required. Improved systems can help reduce error rates, such as electronic prescribing and automated dispensing. Reporting all drug errors and near misses, regardless of whether the patient came to harm, and having processes to investigate and analyse the data is crucial. It is only by
building the baseline evidence that health systems can better understand how errors occur, and how to prevent them.
“Use of medicines has increased because of increased adherence to disease-based guidance. The increase in use also results, however, in increased hazards, errors, and adverse events associated with medicines, which can be reduced or even prevented by improving the systems and practice of medication,” WHO, Medication Without Harm, 2023.1
A culture of safety in the health system is necessary to ensure medication safety. With the necessary education, support, and tools, individual health professionals can do much to ensure safe practice.
The “5 Rights” of medication safety can help health professionals who administer drugs to avoid errors4
Best practice dictates that nurses and others carry out the following checks before giving a medication:
1. Right patient: Check the patient’s name using two identifiers (e.g., wristband, prescription) and the patient to identify themself if he or she is able.
2. Right drug: Check the medication label against what has been prescribed.
3. Right dose: Confirm the dose using current references, such as local protocols or the British National Formulary (BNF). If necessary, recalculate the dose and have a colleague check it.
4. Right route: Check the appropriateness of the prescribed route and confirm with the patient if they are able to take the medicine that way. For example, can they swallow a tablet or capsule?
MEDICATION ERRORS ARE A MULTIFACETED PROBLEM, THERE IS NO ONE SIZE FITS ALL SOLUTION. RATHER, TAILORED APPROACHES TO UNDERSTANDING AND MITIGATING THE RISKS ARE REQUIRED. IMPROVED SYSTEMS CAN HELP REDUCE ERROR RATES, SUCH AS ELECTRONIC PRESCRIBING AND AUTOMATED DISPENSING. REPORTING ALL DRUG ERRORS AND NEAR MISSES, REGARDLESS OF WHETHER THE PATIENT CAME TO HARM, AND HAVING PROCESSES TO INVESTIGATE AND ANALYSE THE DATA IS CRUCIAL.
5. Right time: Check the frequency of the prescribed medication and confirm when the last dose was given. Health professionals should use all available evidence-based resources to keep their knowledge and skills up to date.
MedicinesComplete
MedicinesComplete brings regularly updated medicine information and expert guidance on the use and administration of drugs together in one place, helping health professionals use medicines safely and avoid medication errors. Register for this upcoming webinar to learn how MedicinesComplete can support you in implementing effective processes to reduce medication errors and improve patient safety: https://tinyurl.com/37yftbar
Discover how MedicinesComplete supports health professionals in confident decision-making at the point of need here https://tinyurl.com/599eeetp
Pharmaceutical Press
Trusted worldwide for providing evidencebased pharmaceutical knowledge to improve patient safety, we support health professionals to quickly and confidently make the most informed decisions on the safe and effective use of medicines. Our essential knowledge products are referred to daily by health professionals globally, across healthcare, academic and research settings and relied on by many commercial organisations to operate their businesses. As the Royal Pharmaceutical Society’s Knowledge Business, we invest our resources into creating world-class tools that promote best practice in medicines use, which means health professionals can quickly and confidently make the most informed decisions.
Aronson, J. K. (2009). Medication errors: what they are, how they happen, and how to avoid them. QJM: An International Journal of Medicine, 102(8), 513-521.
www.PharmaceuticalPress.com
REFERENCES
1. WHO. (2023). Medication without harm. Available at: https://iris.who.int/bitstream/hand le/10665/376212/9789240062764-eng.pdf. Last accessed: 22 April 2024.
2. Panagioti M., Khan K., Keers R.N., Abuzour A., Phipps D., Kontopantelis E., et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: Systematic review and meta-analysis. BMJ. 2019;366:I4185. doi: 10.11136/bmj.I4185.
3. Aronson, J. K. (2009). Medication errors: what they are, how they happen, and how to avoid them. QJM: An International Journal of Medicine, 102(8), 513-521.
4. Hanson, A., & Haddad, L. M. (2022). Nursing rights of medication administration. In StatPearls [Internet]. StatPearls Publishing.
The
Strategic Significance of Opening a Regional Headquarter
in Saudi Arabia
Sysmex announces the official grand opening of Sysmex Saudi Regional Headquarter in Riyadh, Saudi Arabia
In an era where global businesses are seeking to expand their footprints in emerging markets, the decision to establish a regional headquarters in Saudi Arabia is both timely and strategic. As the largest economy in the Middle East and a pivotal player in the global energy market, Saudi Arabia offers unparalleled opportunities for companies looking to tap into the region's growing potential.
Sysmex, a global leader in diagnostics and healthcare technology, officially opened its new regional headquarters in Riyadh, Saudi Arabia in October 2024. This expansion reflects Sysmex's commitment to the Middle Eastern market, especially in diagnostics, where it provides advanced healthcare and laboratory solutions. The ceremony was attended by top officials, including H.E Fumio Iwai who currently serves as the Ambassador of Japan in
Saudi Arabia, Sysmex’s global senior executives, Sysmex's Europe, and our regional leaders, who highlighted the importance of closer proximity to customers in Saudi Arabia.
Wissam Daoud, Managing Director of Sysmex Saudi Arabia, emphasized the strategic advantage of having a direct presence in the region. This enables Sysmex to offer agile, high-quality support and innovative diagnostics, better meeting local needs in healthcare services. The facility aims to bolster Sysmex’s capacity to support clinical laboratories across the kingdom, aligning with Saudi Arabia’s goals for healthcare modernization and accessibility.
A Strategic Location
Saudi Arabia's location at the crossroads of Asia, Africa, and Europe makes it an ideal hub
SYSMEX, A GLOBAL LEADER IN DIAGNOSTICS AND HEALTHCARE TECHNOLOGY, OFFICIALLY OPENED ITS NEW REGIONAL HEADQUARTERS IN RIYADH, SAUDI ARABIA IN OCTOBER 2024
for regional operations. With its proximity to key markets in the Middle East, as well as its growing connectivity to the rest of the world, Saudi Arabia provides a logistical advantage that few other locations can match. The establishment of a regional headquarters here allows companies to efficiently manage their operations across these diverse and dynamic markets, while also benefiting from the country's robust infrastructure and ambitious development plans.
Vision 2030: A New Era of Growth
Central to Saudi Arabia's appeal is its Vision 2030 initiative, a bold and ambitious plan to diversify the economy away from its dependence on oil. This vision is creating new opportunities in sectors such as technology, healthcare, tourism, and renewable energy, making Saudi Arabia an attractive destination for investment and business expansion. By opening a regional headquarters in the Kingdom, companies can position themselves at the forefront of this transformation, aligning with the government's efforts to build a more sustainable and diversified economy.
Regulatory Reforms and Ease of Doing Business
Saudi Arabia has made significant strides in improving its business environment, with regulatory reforms designed to attract foreign investment and foster innovation. The establishment of the Saudi Arabian General Investment Authority (SAGIA), along with
other initiatives aimed at simplifying business procedures and enhancing transparency, reflects the Kingdom's commitment to becoming a global business hub. Companies that choose to establish their regional headquarters in Saudi Arabia will benefit from a more streamlined and supportive regulatory framework, reducing barriers to entry and facilitating long-term success.
Cultural and Economic Influence
Saudi Arabia's cultural and economic influence in the region cannot be overstated. As the birthplace of Islam and the custodian of its two holiest sites, the Kingdom holds a unique position in the Muslim world. This cultural significance, combined with its economic clout, makes Saudi Arabia a key partner for businesses looking to expand their influence in the MENA region. A regional headquarters in the Kingdom not only signals a company's commitment to the region but also provides a platform to engage more deeply with local communities and stakeholders.
Sysmex Healthcare Regional Headquarter
Symex announces its grand opening in Riyadh, Saudi Arabia. Opening a regional headquarters in Saudi Arabia is a strategic move that aligns
CENTRAL TO SAUDI ARABIA'S APPEAL IS ITS VISION 2030 INITIATIVE, A BOLD AND AMBITIOUS PLAN TO DIVERSIFY THE ECONOMY AWAY FROM ITS DEPENDENCE ON OIL. THIS VISION IS CREATING NEW OPPORTUNITIES IN SECTORS SUCH AS TECHNOLOGY, HEALTHCARE, TOURISM, AND RENEWABLE ENERGY, MAKING SAUDI ARABIA AN ATTRACTIVE DESTINATION FOR INVESTMENT AND BUSINESS EXPANSION
with the global trend of companies seeking to capitalize on emerging markets. With its strategic location, ambitious economic reforms, and cultural influence, Saudi Arabia offers a unique and compelling proposition for businesses looking to establish a strong regional presence. As the Kingdom continues to evolve and diversify its economy, those who invest in its future today will be well-positioned to reap the rewards of tomorrow.
Establishing a Regional Headquarters in Saudi Arabia Aligned with Vision 2030
As global companies seek to expand their influence and operations in emerging markets, establishing a regional headquarters in Saudi
Arabia represents a forward-thinking and strategic decision. The Kingdom's Vision 2030 initiative, launched by Crown Prince Mohammed bin Salman, serves as a blueprint for transforming Saudi Arabia's economy and positioning it as a global hub for innovation, investment, and sustainable development. Aligning with this vision not only provides businesses with new opportunities but also allows them to contribute to the Kingdom's ambitious transformation.
Strategic Positioning in a Transforming Economy
Saudi Arabia's Vision 2030 is centered on reducing the country's dependence on oil, diversifying its economy, and fostering
THE KINGDOM'S VISION 2030 INITIATIVE, LAUNCHED BY CROWN PRINCE MOHAMMED BIN SALMAN, SERVES AS A BLUEPRINT FOR TRANSFORMING SAUDI ARABIA'S ECONOMY AND POSITIONING IT AS A GLOBAL HUB FOR INNOVATION, INVESTMENT, AND SUSTAINABLE DEVELOPMENT. ALIGNING WITH THIS VISION NOT ONLY PROVIDES BUSINESSES WITH NEW OPPORTUNITIES BUT ALSO ALLOWS THEM TO CONTRIBUTE TO THE KINGDOM'S AMBITIOUS TRANSFORMATION.
a knowledge-based society. By opening a regional headquarters in Saudi Arabia, companies can position themselves at the heart of this transformation, gaining early access to emerging sectors such as technology, renewable energy, healthcare, and tourism. The Kingdom's commitment to creating a diversified and sustainable economy offers companies a stable and forward-looking environment in which to grow and innovate.
Capitalizing on Regulatory Reforms
A key pillar of Vision 2030 is the improvement of the business environment through regulatory reforms aimed at attracting foreign investment and encouraging entrepreneurship. The establishment of new legal frameworks, the reduction of bureaucratic hurdles, and the introduction of incentives for foreign businesses have made it easier than ever for international companies to establish and expand their operations in Saudi Arabia. By setting up a regional headquarters, businesses can benefit from these reforms, positioning themselves for long-term success in a market that is increasingly open and competitive.
Enhancing Connectivity and Infrastructure
Saudi Arabia is investing heavily in infrastructure projects that are designed to enhance connectivity both within the Kingdom and with the wider world. The development of smart cities like NEOM, the expansion of transport networks, and the modernization of telecommunications are all part of the Vision 2030 framework. A regional headquarters in Saudi Arabia allows Sysmex with direct access to these infrastructure developments, allowing them to efficiently manage operations across the Middle East, North Africa, and beyond. This enhanced connectivity also facilitates better collaboration with regional partners and clients, driving business growth.
A Commitment to Sustainability and Innovation
Sysmex emphasizes sustainability and innovation as core components of the business.
The Kingdom is making significant investments in renewable energy, environmental conservation, and cutting-edge technologies, positioning itself as a leader in the global shift towards sustainability. Sysmex aligns with these priorities by establishing a presence in Saudi Arabia which can not only contribute to the Kingdom's sustainability goals but also leverage these initiatives to enhance its own corporate social responsibility and innovation agendas.
Cultural Integration and Market Access
Saudi Arabia's rich cultural heritage and its role as a leader in the Muslim world make it a pivotal market in the Middle East. Vision 2030 aims to preserve and promote this cultural heritage while opening the country to greater global engagement. A regional headquarters in Saudi Arabia offers Sysmex a unique opportunity to integrate with local culture, build strong relationships with stakeholders, and gain deeper insights into the preferences and needs of the local market. This cultural integration, combined with the economic benefits of operating in the Kingdom, enhances the company's ability to succeed in the region.
Conclusion
Aligning with Saudi Arabia's Vision 2030 by establishing a regional headquarters in the Kingdom is a strategic move that allows Sysmex to position itself at the forefront of one of the most ambitious economic transformations in the world.
As Saudi Arabia continues to evolve, businesses that invest in this vision today will be well-positioned to thrive in a dynamic and rapidly growing market. By embracing the opportunities presented by Vision 2030, companies can not only drive their own growth but also contribute to the realization of a prosperous and sustainable future for Saudi Arabia.
A REGIONAL HEADQUARTERS IN SAUDI ARABIA ALLOWS SYSMEX WITH DIRECT ACCESS TO THESE INFRASTRUCTURE DEVELOPMENTS, ALLOWING THEM TO EFFICIENTLY MANAGE OPERATIONS ACROSS THE MIDDLE EAST, NORTH AFRICA, AND BEYOND. THIS ENHANCED CONNECTIVITY ALSO FACILITATES BETTER COLLABORATION WITH REGIONAL PARTNERS AND CLIENTS, DRIVING BUSINESS GROWTH.
Revolutionizing Cancer Treatment: New Perspectives and Enhanced Quality of Life
The field of oncology is experiencing significant advancements in cancer treatment. Ongoing research is leading to the development of more effective therapies, providing patients with renewed hope for a better life. This promising scientific progress inspires optimism about achieving more milestones in the battle against this disease. Recent advancements in cancer treatment significantly impact millions of patients, enabling successful treatment for many previously fatal cancers. These developments improve survival rates and enhance patients' quality of life. As research evolves, we expect personalized therapies based on genetic analyses of tumors and the use of artificial intelligence (AI) to accelerate drug discovery and treatment planning. While progress is encouraging, much work remains. By investing in research and fostering collaboration among experts, we can continue to make strides in combating cancer and improving patient lives.
CAR-T Cell Therapy
CAR-T cell therapy is a major advancement in cancer treatment, offering new options for difficult-to-treat cancers. This innovative immunotherapy uses the patient’s own T cells, a type of white blood cell, which are genetically modified to recognize and destroy cancer cells more effectively. While CAR-T cell therapy has shown promising results, especially in blood cancers like leukemia and lymphoma, researchers are working to expand its use to solid tumors. The therapy is highly personalized, ensuring that each patient's T cells are tailored for targeted treatment, which helps to minimize damage to healthy tissue.
CAR-T CELL THERAPY IS A MAJOR ADVANCEMENT IN CANCER TREATMENT, OFFERING NEW OPTIONS FOR DIFFICULT-TO-TREAT CANCERS.
Immune Checkpoint Inhibitors
Immune checkpoint inhibitors are a new class of cancer treatment drugs that enhance the body’s immune system to better target and attack cancer cells. Immune checkpoints naturally prevent the immune system from attacking healthy cells, protecting tissues and preventing autoimmune diseases. By blocking these checkpoints, immune checkpoint inhibitors allow immune cells to effectively fight cancers like melanoma, lung cancer, and bladder cancer. Their effectiveness varies with different cancer types, as some respond better than others.
Improvements in Radiation Therapy
Radiation therapy has significantly advanced in recent years, becoming more precise and effective while minimizing side effects and improving patients' quality of life. New techniques, such as proton therapy and stereotactic body radiation therapy (SBRT), allow for targeted treatment of tumors with reduced damage to healthy tissue.
These innovations enhance the effectiveness of treatment and lower the risk of recurrence, making daily life more manageable for patients. Radiation therapy is used for various cancer types at different stages, either as a standalone treatment or alongside other therapies.
Precision Medicine
Precision medicine is an innovative approach to cancer treatment that analyzes the genetic makeup of tumors to create personalized treatment plans for each patient. Unlike traditional methods, which apply the same treatment to all, precision medicine uses samples from cancerous tumors to identify specific genetic mutations driving tumor growth. These mutations are matched with targeted drugs, allowing for tailored therapies. While this method can improve treatment effectiveness and reduce side effects, not all cancers have targetable mutations. Researchers are actively working to expand the use of precision medicine and develop more targeted
therapies, ultimately enhancing the quality of life for cancer patients.
Monoclonal Antibodies and Targeted Therapies
Monoclonal antibodies are crucial in treating various cancers, specifically targeting cancer cells with fewer side effects than traditional chemotherapy. New targeted therapies are emerging, improving survival rates for tumors resistant to other treatments.
These laboratory-produced proteins act like guided missiles, binding to specific materials on cancer cell surfaces and leading to their destruction. Highly selective, they work best for cancers with particular cell surface markers. While they have improved outcomes for many, their effectiveness can vary based on individual patient factors.
The power of monoclonal antibodies lies in their diverse mechanisms, which include:
• Direct Binding to Cancer Cells: When an antibody attaches to a cancer cell, it hinders the cell's ability to grow and divide.
• Immune System Activation: Antibodies draw in other immune cells, such as natural killer cells, to the site of the tumor. These immune cells are then activated to attack and destroy the cancer cells.
• Blocking Growth Signals: Some antibodies attach to specific receptors on the surface of cancer cells, preventing these receptors from receiving signals that encourage cell growth.
• Delivering Toxic Substances to Cancer Cells: Toxic substances can be linked to antibodies, which, upon binding, deliver the toxin directly to the cancer cell, effectively destroying it.
Although monoclonal antibodies offer significant benefits, they do not cure all types of cancer, and individual responses to treatment can vary.
RADIATION THERAPY HAS SIGNIFICANTLY ADVANCED IN RECENT YEARS, BECOMING MORE PRECISE AND EFFECTIVE WHILE MINIMIZING SIDE EFFECTS AND IMPROVING PATIENTS' QUALITY OF LIFE. NEW TECHNIQUES, SUCH AS PROTON THERAPY AND STEREOTACTIC BODY RADIATION THERAPY (SBRT), ALLOW FOR TARGETED TREATMENT OF TUMORS WITH REDUCED DAMAGE TO HEALTHY TISSUE.
Cedars-Sinai... Excellence in Healthcare
Cedars-Sinai has been recognized for nine years in a row on the “Best Hospitals” Honor Roll by U.S. News & World Report. Cedars-Sinai’s sterling reputation and worldclass services make it a leading destination for patients worldwide. The U.S. News & World Report rankings place Cedars-Sinai among the top hospitals in the U.S. in multiple healthcare specialties, including Cardiology, Heart & Vascular Surgery; Gastroenterology & GI Surgery; Diabetes & Endocrinology; Neurology & Neurosurgery; Obstetrics & Gynecology; Orthopedics; and Pulmonology & Lung Surgery.
Specialized Care for International Patients
Cedars-Sinai’s groundbreaking research and specialized care have garnered an international reputation for excellence. Also, located in Los Angeles, California, in the beautiful neighborhood of Beverly Hills, Cedars-Sinai provides patients with the rich surroundings of the lively city, known for its
art, culture, music, sporting events, famous landmarks and warm weather.
“Every year, thousands of patients come to Cedars-Sinai from around the world,” said Heitham Hassoun, MD, Chief Executive of Cedars-Sinai International, which is responsible for overseas patients and collaborations with hospitals and healthcare systems outside of the U.S. “We care for patients from more than 100 countries every year. Many need to be treated for complex conditions that the healthcare systems in their home countries are not yet able to manage.”
This year, and for the second consecutive time, Global Healthcare Accreditation has recognized Cedars-Sinai for providing international patients with the highest-quality healthcare in the U.S. An exceptional level of personalized concierge care is available to international patients at Cedars-Sinai, including assistance with short- or long-term housing,
EVERY YEAR, THOUSANDS OF PATIENTS COME TO CEDARS-SINAI FROM AROUND THE WORLD.
DR. HEITHAM HASSOUN
airline ticketing, ground transportation and medical document review.
Cedars-Sinai’s physicians create individual treatment plans for all international patients, and our multilingual staff provides support and advice throughout the full cycle of care.
Last year, Cedars-Sinai opened its International Lounge, a place where patients and their companions can relax in comfort. It includes a quiet room for meditation and prayer as well as conference rooms for meetings and consultations, among other amenities.
“Our goal is to support patients and their families and to make them feel comfortable throughout their care journey. Emotional support is critical to overall health, and we want them to know they have a team by their side at all times,” said Christina Khatchadourian, Concierge Services lead. “Sometimes the little things can make a big difference.”
Big Changes
“There are big changes taking place in 21st century global healthcare,” Dr. Hassoun said. “Impressive new healthcare facilities are being established in key regions, including the Middle East, Southeast Asia, Eastern Europe and Latin America. Cedars-Sinai continues to expand our collaboration with facilities around the globe.”
With a regional office having opened in Mexico City in 2023 and another having opened in Singapore earlier this year, Cedars-Sinai now has multiple regional offices—and more are planned in Ecuador, Qatar and elsewhere.
“By meeting patients where they are, we can connect them with expert care providers at
Cedars-Sinai and help coordinate their medical travel to Los Angeles or provide remote video consultations,” said Benjamin Seo, CedarsSinai International’s director of Global Business Development. “We’re working to support local healthcare and, at the same time, provide the best possible experience for those who are able to travel to our medical center in Los Angeles.”
It’s All About the Patient
Cedars-Sinai’s Patient Experience team continues to strive for excellence at every level of healthcare services.
“Our global network continues to grow, and our expert doctors, nurses, researchers and managers are now reaching people all over the world,” Dr. Hassoun said. “But I can guarantee that one thing won’t change: The patient is at the center of everything we do. Everyone who comes to Cedars-Sinai can trust that they will receive the very highest quality of healthcare from people who are dedicated to their wellbeing and progress.”
CEDARS-SINAI’S PHYSICIANS CREATE INDIVIDUAL TREATMENT PLANS FOR ALL INTERNATIONAL PATIENTS, AND OUR MULTILINGUAL STAFF PROVIDES SUPPORT AND ADVICE THROUGHOUT THE FULL CYCLE OF CARE. LAST YEAR, CEDARSSINAI OPENED ITS INTERNATIONAL LOUNGE, A PLACE WHERE PATIENTS AND THEIR COMPANIONS CAN RELAX IN COMFORT.
"EspritTM BTK System is a first-of-its-kind dissolvable stent for people with severe form of Peripheral Artery Disease PAD."
Samih
Al Mawass, Division Vice President for Abbott’s vascular business, EMEA
The UAE has once again solidified its position as a regional leader in healthcare innovation by becoming the first country in the EMEA region to implement Abbott’s EspritTM BTK system, a breakthrough dissolvable stent designed for patients with Chronic Limb-Threatening Ischemia (CLTI) and severe Peripheral Artery Disease (PAD) below the knee. Hospitals Magazine had the privilege to explore the significance of this milestone with Samih Al Mawass, Division Vice President for Abbott’s Vascular Business in EMEA. In this exclusive interview, Al Mawass shares insights into the impact of the EspritTM BTK system on the UAE’s healthcare landscape, Abbott’s strategic vision for expanding advanced healthcare solutions across the region, and the essential role of innovation in addressing some of the most pressing cardiovascular challenges.
The UAE recently became the first country in the EMEA region to implement the EspritTM BTK system. What is the significance of this milestone for the UAE’s healthcare landscape and Abbott’s presence in the region?
The United Arab Emirates has consistently demonstrated its commitment to innovation, particularly in the healthcare sector, which it highly prioritizes. By becoming the first country in the EMEA region to implant EspritTM BTK, the UAE reinforces its status as a healthcare hub. This milestone not only enhances the country's reputation but also signifies a transformative shift in patient care and treatment options in the region.
For Abbott, this achievement presents a unique opportunity to strengthen our commitment to the region and align our
PERIPHERAL ARTERY DISEASE (PAD) IS HIGHLY PREVALENT, YET MANY PEOPLE HAVE NEVER HEARD OF THE CONDITION. MORE THAN 200 MILLION PEOPLE WORLDWIDE HAVE PAD, WITH NEARLY 11% AFFECTED BY CLTI1,2. IT’S A CONDITION THAT OCCURS WHEN THE ARTERIES BECOME CLOGGED WITH PLAQUE, PREVENTING BLOOD FLOW AND OXYGEN FROM REACHING THE LOWER LEGS AND FEET. THERE HAVE BEEN LIMITED TREATMENT OPTIONS APPROVED FOR BLOCKED ARTERIES BELOW THE KNEE
solutions with the UAE's vision for advanced medical technologies and improved patient outcomes.
How does the successful implantation in the UAE align with Abbott's broader strategy to expand innovative healthcare solutions across Europe, the Middle East, and Africa?
Since it was founded in 1888, Abbott has remained dedicated to empowering individuals to lead healthier, fuller lives. Today, our 114,000 colleagues serve people in over 160 countries worldwide, delivering life-changing technologies across the healthcare spectrum. By introducing Esprit™ BTK System in the UAE, we underscore our commitment to providing patients and their healthcare providers across the region with innovative products and solutions designed to enhance health outcomes and promote well-being.
How do you think EspritTM BTK will address the growing challenges of treating peripheral artery disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI), amidst the increasing prevalence of chronic diseases?
Peripheral Artery Disease (PAD) is highly prevalent, yet many people have never heard of the condition. More than 200 million people worldwide have PAD, with nearly 11% affected by CLTI1,2. It’s a condition that occurs when the arteries become clogged with plaque, preventing blood flow and oxygen from reaching the lower legs and feet. There have been limited treatment options approved for blocked arteries below the knee. EspritTM BTK System is a first-of-its-kind dissolvable stent, approved by the U.S. Food and
Drug Administration in April 2024 for people with a severe form of PAD, which is CLTI below-theknee (BTK). It is designed to keep arteries open and deliver a drug called everolimus to support vessel healing prior to dissolving.
Healthcare in a competitive market. What’s your strategy to strengthen leadership worldwide and in the Middle East?
At Abbott, we put the people we serve at the heart of everything we do, designing our products with the same care as if they were for our own families. As a global healthcare leader, we proactively identify and address the world’s greatest health challenges by developing breakthrough-tailored solutions.
Leveraging our 135-year legacy and deep understanding of local market dynamics, we consistently deliver unique and meaningful experiences to our customers, ensuring that every interaction with our team or our lifechanging products is a memorable one.
Innovation is key in the vascular field. How does Abbott drive innovation to tackle emerging challenges in cardiovascular care?
Innovation is fundamental to Abbott’s strategy, in the vascular field but also across all our business portfolio. We prioritize understanding current health needs while anticipating future challenges, which allows us to stay at the forefront of cutting-edge healthcare solutions. Our goal is to equip healthcare providers with the right tools and technologies precisely when needed, enabling them to deliver optimal patient care and achieve outstanding clinical outcomes.
INTERVIEWS WE PRIORITIZE UNDERSTANDING CURRENT HEALTH NEEDS WHILE ANTICIPATING FUTURE CHALLENGES, WHICH ALLOWS US TO STAY AT THE FOREFRONT OF CUTTING-EDGE HEALTHCARE SOLUTIONS. OUR GOAL IS TO EQUIP HEALTHCARE PROVIDERS WITH THE RIGHT TOOLS AND TECHNOLOGIES PRECISELY WHEN NEEDED, ENABLING THEM TO DELIVER OPTIMAL PATIENT CARE AND ACHIEVE OUTSTANDING CLINICAL OUTCOMES
REFERENCES
1. Fowkes, F.G., et al., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet, 2013. 382(9901): p. 1329-40.
2. Nehler, M.R., et al., Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg, 2014. 60(3): p. 686-95 e2.
Novel Intraoperative Imaging Device Advances Precision Surgery for Patients with Cancer
The Dynamic Optical Contrast Imaging (DOCI) device is a revolutionary, noninvasive imaging system that utilizes advanced high-speed cameras and LED lights to delineate margins between malignant and healthy tissue in real-time.
This pioneering imaging device, created by a UCLA Health surgeon, does not require the use of injectables or dyes like traditional canceridentifying devices.
The DOCI system was created by Maie St. John, MD, PhD, Professor and Chair of the Department of Head and Neck Surgery at UCLA Health; Professor of Bioengineering; and Thomas C. Calcaterra Chair of Head and Neck Surgery. This new device has demonstrated
a high degree of accuracy in identifying the difference between cancerous and healthy tissues over the course of its trials among 150 patients at UCLA Health.
The current usage of the device has been focused on neck squamous cell carcinoma among other head and neck cancers; however, Dr. St. John has emphasized an interest in a broader use of the technology to identify cancer in general. Dr. St. John is hopeful that the DOCI system can help with patient care and significantly improve patient outcomes and survival.
A Delicate Balance
The device has proven to be essential in
THE TERM THERANOSTICS COMES FROM THE COMBINATION OF THERAPEUTICS AND DIAGNOSTICS.
accurately identifying head and neck cancers, which are the most difficult to diagnose. In addition, more than 90% of head and neck cancer develops in the cells lining the mouth and throat, which often have been particularly challenging to identify. The prognosis is often diminished by factors such as cancer cells still living after tumors have been removed and even cancers that grow around the nerves. This is particularly crucial as surgeons want to remove the cancerous tissue completely without risking healthy tissue. If cancerous tissue remains, UCLA Health doctors have noted, it can increase the likelihood that the cancer will return, and even the risk of death, by 90%.
Accurately determining these margins is crucial, and the gap in current technology can cause poor outcomes such as decreased quality of life and a lower survival rate.
Birth of DOCI
In collaboration with engineering departments at UCLA Health and the Head and Neck Surgery Department, Dr. St. John came up with the innovative idea after realizing her Toyota Prius had sensors that would allow her not to drive into the hedges of her front lawn. Dr. St. John sought to create a machine that can effectively use the idea of a “sensor” that can detect cancer versus non-cancer margins while also finding the lowest cancer cell concentration per volume of tissue.
How It Works
The system quickly proved its value, as tumors that were previously almost impossible to detect using existing imaging techniques were suddenly clearly identifiable. The findings of the test were extremely promising, with DOCI imaging able to detect perineural invasion with 100% accuracy, compared to the control group.
With such promising results, Dr. St. John and her team are looking to promote broader clinical uses of the DOCI system. Their first step will be to make it useful in endoscopes, enabling surgeons to see how it can be utilized during throat surgery. To further evaluate its usage, Dr. St. John is working with experts across the country to test it with other cancers and specialties such as breast and colorectal surgeries.
OFFERING STATE-OFTHE-ART FACILITIES AND EXPERTISE, THE 3,000-SQUAREFOOT OUTPATIENT THERANOSTICS CENTER IN WESTWOOD, PART OF THE UCLA HEALTH JONSSON COMPREHENSIVE CANCER CENTER, SPECIALIZES IN RADIOPHARMACEUTICAL THERAPY. a global leader in smart healthcare
The DOCI system is mounted on a physician's arm and then swung over the patient’s bed in a wide view, while light shines on the area surrounding the tumor that has been identified. The machine uses light energy, a high-speed camera, and regular LED light resulting in two images that are then analyzed at multiple wavelengths. This allows healthcare professionals to see the difference between healthy tissues and non-healthy tissues.
DOCI imaging was initially tested on mice, who were injected subcutaneously into bilateral flanks with SCCVII SF, a neck cancer cell line.
Dr. St. John hopes that, one day, it can also be used for the early detection of cancer by dermatologists, dentists and primary care providers, so that as many patients as possible can have better outcomes while improving their overall quality of life.
For more information, please visit https://www.uclahealth.org/international-services/ or call +1 310-794-8759
WCM-Q program promotes professionalism in medical education in a highly diverse culture
Asymposium and webinar series offered by the Division of Continuing Professional Development at Weill Cornell MedicineQatar (WCM-Q) addressed the challenges associated with fostering professionalism in medical education in Qatar’s highly diverse multicultural context.
The symposium, titled Fostering Professionalism in Medical Education: Exploring Effective Approaches for Diverse Learners, features a full day of interactive sessions led by highly experienced WCM-Q faculty and visiting experts from leading medical education institutions in Europe and the US. Sessions focused on identifying and defining the key attributes of professionalism, examining how conceptions of professionalism vary among different cultures, methodologies to assess professionalism, and discussions about how learners develop their professional identities through education and other experiences.
The sessions also explored how assessment data can be used to inform the professionalism remediation process and optimize coaching, and how to design and implement an appropriate remediation plan using coaching skills. The symposium, which was offered for the first time in June this year, is augmented by a regular webinar series on professionalism in diverse learning contexts.
The symposium was directed and presented by WCM-Q faculty members Dr. Amal Khidir, Associate Professor of Pediatrics; Dr. Fatimah Isa, Assistant Professor of Psychology Teaching in Medicine; Dr. Moune Jabre, Assistant Professor of Clinical Obstetrics and Gynecology; and Dr. Mange Manyama, Assistant Professor of Anatomy in Radiology.
International and Qatar-based speakers included Dr. Adina Kalet, Stephen and Shelagh Roell Endowed Chair at the Medical College of Wisconsin; Dr. Goran Stevanovski, Health Professions Education Consultant and the Founder and Former Director of the Medical Education Department at Ss. Cyril and Methodius University, North Macedonia; Dr. Marianne Mak-van der Vossen, Assistant Professor of General Practice at Amsterdam University Medical Center (UMC); and Dr. Majda Sebah, Assistant Professor of Chemistry in PreMedical Education at WCM-Q.
Reflecting on the coaching model that can be used to help healthcare professionals develop professionalism and cultural awareness, Dr. Fatimah Isa stressed that the aim was to empower healthcare professionals by equipping them with new skills. She said: “To develop and/ or improve professionalism in diverse learning environments, it is essential that we reflect on
"THE SYMPOSIUM WAS DIRECTED AND PRESENTED BY WCM-Q FACULTY MEMBERS DR. AMAL KHIDIR, ASSOCIATE PROFESSOR OF PEDIATRICS; DR. FATIMAH ISA, ASSISTANT PROFESSOR OF PSYCHOLOGY TEACHING IN MEDICINE; DR. MOUNE JABRE, ASSISTANT PROFESSOR OF CLINICAL OBSTETRICS AND GYNECOLOGY; AND DR. MANGE MANYAMA, ASSISTANT PROFESSOR OF ANATOMY IN RADIOLOGY".
Dr. Fatimah Isa Dr. Mange Manyama Dr. Moune Jabre
Dr. Amal Khidir
how people from other cultures perceive our behavior. Also, we need to consider various factors—it is not only about behavior but also attitude, morals, values, and so on. For this session [at the symposium], I used a model rooted in the Schön reflection model with the humanistic approach and framed it to reflect some ICF (International Coaching Federation) core competencies. This approach empowers healthcare professionals to reflect, explore options, and formulate an action plan to achieve the desired results. The role of a coach is facilitating the process rather than instructing or directing them, and reflection is the key to this coaching process.”
The symposium and webinar series were accredited locally by the Ministry of Public Health’s Department of Healthcare Professions – Accreditation Section and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
Dr. Mange Manyama explained that professionalism in diverse learning environments is assessed through multiple dimensions that reflect cultural sensitivity and inclusive practices. “Some of the important aspects evaluated include communication skills, cultural competence, adaptability, collaboration abilities, ethical behavior, ability to create an inclusive atmosphere, language sensitivity, conflict resolution skills, and receptivity to feedback from diverse sources,” he said. “The evaluation process usually focuses on an individual's ability to interact respectfully with peers and instructors from various backgrounds, understand and respect diverse perspectives, adjust approaches based on different cultural contexts, work effectively in diverse teams, and adhere to ethical standards that consider cultural variations.”
Dr. Moune Jabre said: “Medical professionalism is a set of values, behaviors, and relationships centered on trust, integrity, and accountability,
that prioritize patient welfare and societal well-being. It encompasses a commitment to ethical behavior, compassion, and continuous self-assessment to adapt and grow. “Clinical experiences, mentorship, and reflection, coupled with regular assessment, feedback and diverse, real-world learning opportunities, foster professional identity formation in trainee physicians. In this way, learners develop the skills necessary to navigate and contribute positively to increasingly multicultural academic and professional environments. Assessment methods may include peer evaluations, selfreflections, case studies, role-playing exercises, and observations of group interactions.”
Another of the learning objectives of the program is to equip the participants with the skills and knowledge to apply culturally adept coaching skills in interacting with learners. Dr. Amal Khidir said: “The diverse learning environment includes learners, instructors, staff and patients from diverse cultural backgrounds; learners in such environment usually acquire humility and soft skills. Exposure to a variety of cultures, styles and professionals from different backgrounds supports the learner’s professional identity formation, which is the process that leads to thinking, feeling and acting like a physician. The learner educated in a diverse environment will gain the ability to cope and handle patients from different cultures and backgrounds.”
"THE SYMPOSIUM AND WEBINAR SERIES WERE ACCREDITED LOCALLY BY THE MINISTRY OF PUBLIC HEALTH’S DEPARTMENT OF HEALTHCARE PROFESSIONS –ACCREDITATION SECTION AND INTERNATIONALLY BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME)."
Mia®: Harmonizing Your Curves, Naturally
Dr. Rabih Maatouk, Plastic Surgeon in Abu Dhabi at Harley Street Medical Center
Mia® offers a less invasive and more convenient option for women seeking subtle breast enhancement. It focuses on harmonizing the breast shape and size rather than significant augmentation. Hospitals magazine recently interviewed Dr. Rabih Maatouk, a Plastic Surgeon in Abu Dhabi at Harley Street Medical Center, about Mia® and its advantages.
INTERVIEWS
Tell us about your journey; what inspired you to specialize in plastic surgery, particularly breast surgery?
After completing medical school, I was drawn to surgical specialties with a clinical component. Initially, I considered gynecology and obstetrics. However, a fellow plastic surgeon inspired me to pursue plastic surgery. My first surgical experience, assisting in breast reduction, was truly magical. At one point, the breast seemed unrecognizable. I jokingly worried we might face legal trouble, but the surgeon skilfully manipulated the skin and tissue to create a smaller, lifted breast. At that moment, I solidified my decision to specialize in plastic surgery, particularly breast surgery.
What concerns do women typically have before breast surgery, and how do you address them?
Women often have several concerns before undergoing breast surgery. Here are some of the most common ones and how surgeons typically address them:
• Desired Outcome: women may be unsure about the ideal implant size and shape. Surgeons often discuss these options, sometimes using visual aids, to help them visualize potential results and make informed decisions.
• Anesthesia: women may be anxious about the anesthesia process. Surgeons explain the type of anesthesia (general or local) most suitable for their procedure and address any concerns they may have.
• Post-Operative Pain and Recovery: women may worry about pain and discomfort after surgery. Surgeons discuss pain management strategies, including medication and nerve blocks, to minimize discomfort and expedite recovery.
By addressing these concerns, surgeons aim to alleviate women's anxiety and ensure they feel confident and prepared for their procedure.
In detail, can you introduce us to Mia®, the breast harmonization
procedure? With Mia® now available, have women's concerns about breast surgery been minimized? Mia® is a minimally invasive technique designed to enhance breast size. It focuses on harmonizing the breast shape and size rather than significant augmentation. This procedure typically increases the breast size by one or, at most, two cup sizes. The implant sizes available for Mia® aren't designed for dramatic augmentation but for subtle enhancement. Mia® is considered a procedure rather than surgery due to its minimal invasiveness. It takes only 15-20 minutes to perform, and a woman can usually leave the clinic within a few hours. Moreover, post-operative pain is minimal. In addition to its minimal invasiveness and quick recovery time, Mia® offers several other advantages:
• Natural-looking results: Mia® implants are designed to mimic the natural shape and feel of the breast.
• Versatility: Mia® can address a variety of breast concerns, including asymmetry, insufficient volume, and sagging.
• Safety: Mia® is a well-established procedure with a proven safety record.
• Minimal scarring: The implant is exclusively inserted through a 2cm scar in the armpit.
If a woman is considering breast enhancement, Mia® may be a great option. It's a safe, effective, and minimally invasive solution. Medica Group, distributor company specialized in aesthetic medicine, is bringing Mia® to the Middle East.
How does Mia® technology work, and what makes it a game-changer in breast harmonization?
Mia® is a revolutionary technology that offers a minimally invasive approach to breast enhancement. It involves small incisions in the underarm or around the areola to insert specially designed implants. Unlike traditional methods, Mia® preserves natural breast tissue,
MIA® IS A REVOLUTIONARY TECHNOLOGY THAT OFFERS A MINIMALLY INVASIVE APPROACH TO BREAST ENHANCEMENT. IT INVOLVES SMALL INCISIONS IN THE UNDERARM OR AROUND THE AREOLA TO INSERT SPECIALLY DESIGNED IMPLANTS. UNLIKE TRADITIONAL METHODS, MIA® PRESERVES NATURAL BREAST TISSUE, LEADING TO MINIMAL SCARRING AND A FASTER RECOVERY TIME
leading to minimal scarring and a faster recovery time. The implants are strategically placed to create a natural, lifted, and fuller look without compromising the breast's original shape or sensation. Mia® stands out as a game-changer due to its numerous advantages. Its minimally invasive natural results in minimal scarring, often hidden in natural skin folds. The quick recovery period allows women to return to their daily activities sooner. By prioritizing the preservation of natural breast tissue, Mia® ensures harmonious and aesthetically pleasing results. Local anesthesia enhances the procedure's comfort, and the overall outcome empowers women to feel more confident in their appearance.
We've heard that women can preserve their breast tissue during the Mia® procedure. Can you explain what that means and why it's important?
Mia® technique offers a minimally invasive alternative that prioritizes tissue preservation. A tiny balloon inserted through an incision in the armpit creates a pocket without the need for cutting through breast tissue. This innovative approach significantly reduces the risk of nerve damage, minimizes scarring, and leads to a quicker recovery. As a result, women can experience less pain, swelling, and discomfort and achieve more natural-looking results with minimal downtime.
Are all women potential candidates for Mia®, or are there specific criteria?
Mia® is not suitable for all women. Previous breast surgery, significant sagging, breast asymmetry, and the desire for a dramatic size increase can make a woman a less ideal candidate for this procedure. Women with these conditions should consult a qualified plastic surgeon to determine the most appropriate treatment for their specific needs.
What happens if a woman is not satisfied with the results of her Mia® procedure?
Mia®’s unique tissue-preservation technique makes the procedure 100% reversible.
Implants can be removed at any time. The removal process is designed to be minimally invasive, often utilizing the same underarm incision made during the initial implant placement. This approach aims to minimize scarring and discomfort.
What message would you share to inspire all the women reading this article to consider Mia® for their breast enhancement journey?
My message to all women reading this article is that Mia® presents an appealing option for women seeking a natural-looking breast enhancement with minimal downtime. If you're unsatisfied with your current breast size and desire a procedure that prioritizes both aesthetics and convenience, Mia® could be a suitable choice. While there have been no reported complications thus far, it's crucial to consult with a qualified surgeon to assess individual suitability. Mia® offers a less invasive approach and a quicker recovery time, allowing you to return to your daily activities sooner. Additionally, the lifetime warranty provides reassurance, ensuring that any potential issues with the implants can be addressed by the manufacturer. If you prefer to avoid general anesthesia, Mia® can be performed under local anesthesia, making it a more comfortable and accessible option.
MY MESSAGE TO ALL WOMEN READING THIS ARTICLE IS THAT MIA® PRESENTS AN APPEALING OPTION FOR WOMEN SEEKING A NATURALLOOKING BREAST ENHANCEMENT WITH MINIMAL DOWNTIME
How We Treat “Prostate Cancer” and “Prostate Enlargement” At ACIBADEM
Prostate, a gland in the male urinary system, can be affected by several conditions, with the most common being prostate cancer and prostate enlargement. These diseases are prevalent among men but can be treated effectively, permanently, and safely at hospitals equipped with advanced technology and experienced, skillful surgeons.
At Acıbadem, we provide world-renowned expertise, cutting-edge technologies, a patientcentered approach, and exceptional teamwork to deliver the best care for patients seeking treatment for urological disorders worldwide.
A Precise Solution to Prostate Cancer with Robotic Surgery
Prostate cancer is the most commonly diagnosed cancer in men. The primary treatment for prostate cancer is radical prostatectomy, a surgical procedure that involves the removal of the prostate gland. However, this surgery can be performed using different techniques, including open, laparoscopic, and robotic approaches.
At Acıbadem, we prioritize laparoscopic or robotic surgery allowing surgery through small incisions, over the open approach that requires a 12cm incision in the lower abdomen.
This approach offers significant benefits to patients, including faster recovery and a reduced risk of complications, infections, and blood loss.
ROBOTIC SURGERY IS A MEDICAL TECHNOLOGY THAT ENABLES SURGEONS TO PERFORM OPERATIONS USING ROBOTIC ARMS AND ATTACHED TOOLS.
Professor Ali TEKIN
What is Robotic Surgery?
Robotic surgery is a medical technology that enables surgeons to perform operations using robotic arms and attached tools. The surgeon controls these instruments from a computer console within the operating room. This approach offers several advantages including improved visualization, enhanced deftness, and greater precision, affording the surgeon to achieve better outcomes.
Minimizing Risk of Incontinence and Impotence with Robotic Prostate Surgery
Prostate is located deep within the groin, situated between the bladder and the urethra. It is closely surrounded by vessels and nerves responsible for penile erections and urinary control. Consequently, there exists a risk of damage to these functional tissues while removing the cancerous prostate. Here, robotic surgery plays a crucial role in enabling surgeons to perform more precise operations. Many studies show that a robotic-assisted approach to prostate cancer surgery helps 95% of patients maintain urinary control and 80% preserve erectile function.
At Acıbadem, thanks to our urologists’
AT ACIBADEM UNIVERSITY, THERE IS AN OFFICIAL ROBOTIC SURGERY TRAINING CENTER THAT EDUCATES SURGEONS AND OFFERS A GLOBALLY RECOGNIZED CERTIFICATE AT THE COMPLETION OF TRAINING
extensive experience in robotic prostate cancer surgery, we can not only remove the cancer entirely but also minimize the risk of urinary incontinence and impotence.
Today, the robotic surgery system is employed in five different hospitals within the Acıbadem Healthcare Group. Furthermore, at Acıbadem University, there is an official robotic surgery training center that educates surgeons and offers a globally recognized certificate at the completion of training.
Advanced Treatment Options for Prostate Enlargement
Benign prostate hyperplasia, or benign prostate enlargement, is the most common condition affecting the prostate. Unlike prostate cancer, it is a noncancerous enlargement of the prostate gland. An enlarged prostate can narrow the urinary tract and may lead to the inability to urinate or the incomplete emptying of the bladder. However, it is a completely treatable condition, with a variety of effective treatment techniques available.
Modern treatments for prostate enlargement are minimally invasive and performed without incisions. These procedures involve inserting a cystoscope through the urethra to reach the prostate and using a laser to cut away the enlarged tissue. After the enlarged prostate tissue is cut, it is morcellated in the bladder and removed. There are various devices used to perform this procedure, including HoLEP, ThuLEP, and BipoLEP. The main difference between these devices is the type of energy source used. Lasers peel away the obstructing prostate tissue from the prostatic capsule, like peeling an orange.
A recent advancement in treating benign prostate enlargement is the Rezum procedure. In Rezum, water vapour (steam) is applied at several points spaced one centimeter apart by inserting a needle into the prostate through
the urethra. This shrinks the prostate over time, allowing the urinary channel to open and improving urine flow. Acıbadem is equipped with all the advanced technologies used to treat enlarged prostate, making it one of the few centers worldwide to offer such a comprehensive range of treatment options.
Acıbadem International Patient Center
Acıbadem's expert team, specialized on personalized and comprehensive care, is dedicated to assist you before, during, and after your treatment. You can rest assured that Acıbadem International Patient Center is going to plan every step of your journey elaborately. We welcome you to call or email us if you have any questions or concerns at any time.
AT ACIBADEM, WE PROVIDE WORLDRENOWNED EXPERTISE, CUTTING-EDGE TECHNOLOGIES, A PATIENT-CENTERED APPROACH, AND EXCEPTIONAL TEAMWORK TO DELIVER THE BEST CARE FOR PATIENTS SEEKING TREATMENT FOR UROLOGICAL DISORDERS WORLDWIDE.
Men’s Health Awareness Month: A Step Towards Better Life
Men’s Health Awareness Month offers a chance to reshape how we approach men’s health, encouraging men to prioritize their well-being. Men's health issues are often overlooked, which can allow preventable conditions to worsen over time. This month seeks to correct that gap, promoting proactive health habits among men.
Early detection is crucial for conditions like prostate cancer and heart disease, as they are often treatable when caught early. This month promotes healthier lifestyles, emphasizing regular exercise, a balanced diet, and avoiding smoking. It encourages men to openly discuss health concerns and empowers them to make informed choices. Men’s Health Awareness Month also urges healthcare providers to focus on men's health needs, serving as a call to action to prevent disease and prioritize self-care.
Heart Disease
Why Men's Hearts Need Special Care?
Both biological and lifestyle factors contribute to men's higher risk of heart disease. Aging increases susceptibility, but habits like smoking, a high-fat diet, excess weight, and inactivity are significant contributors. Other risks include high blood pressure, elevated cholesterol, diabetes, a family history of heart disease, and chronic stress. A healthy lifestyle and regular check-ups can help reduce these risks.
• Hormonal Factors: Male hormones like testosterone can increase LDL (bad) cholesterol, contributing to artery hardening, while estrogen (higher in women before menopause) naturally protects blood vessels.
• Lifestyle Choices: Men tend to engage in less healthy habits, including higher rates of smoking, alcohol consumption, and diets high in saturated fats. Smoking damages blood vessels directly, while poor diet and inactivity raise blood pressure, cholesterol, and increase obesity risk— all leading causes of heart disease.
• Social Factors: Many men postpone seeking medical care, ignoring symptoms, which can lead to late diagnoses and more advanced diseases. Social pressures from work or family often contribute to this neglect of health.
• Genetics: Family history is another strong predictor of heart disease risk in men.
Symptoms to Watch For
Heart disease symptoms vary, from mild to severe, and some men may have no symptoms at all. Common signs to watch for include:
• Chest pain or pressure
• Shortness of breath, either with activity or at rest
• Persistent fatigue, even with rest
• Dizziness or fainting
• Irregular heartbeat
• Swelling in the legs and ankles
• Persistent cough, especially at night
• Pain radiating to the jaw, arm, back, or stomach
Since some men, especially older ones, may experience only mild or atypical symptoms, regular screenings are essential, particularly for those with known risk factors. Early detection can significantly improve treatment outcomes and help prevent complications.
Healthy Lifestyle Tips for Heart Disease Prevention
To reduce the risk of heart disease, men should adopt a healthy lifestyle, starting with quitting smoking, as nicotine narrows arteries and increases blood clot risk. Regular physical activity, like brisk walking or swimming, along with a balanced diet rich in fruits, vegetables, and whole grains, is essential. Limiting fatty and sugary foods and managing stress through techniques like meditation or yoga are also important. Lastly, regular check-ups help with early detection and treatment of heart issues.
BOTH BIOLOGICAL AND LIFESTYLE FACTORS
CONTRIBUTE TO MEN'S HIGHER RISK OF HEART DISEASE. AGING INCREASES SUSCEPTIBILITY, BUT HABITS LIKE SMOKING, A HIGH-FAT DIET, EXCESS WEIGHT, AND INACTIVITY ARE SIGNIFICANT CONTRIBUTORS. OTHER RISKS INCLUDE HIGH BLOOD PRESSURE, ELEVATED CHOLESTEROL, DIABETES, A FAMILY HISTORY OF HEART DISEASE, AND CHRONIC STRESS.
Protecting Prostate Gland: Your Shield Against Future Troubles
The prostate gland is a key player in men’s health. Encircling the upper part of the urethra, it serves vital functions in both the urinary and reproductive systems. Understanding how the prostate works, recognizing potential diseases, and committing to regular screenings are essential for early detection and effective treatment. Raising awareness about these proactive steps can empower men to enjoy longer, healthier lives.
Benign Prostatic Hyperplasia (BPH):
Managing an Enlarged Prostate
Benign Prostatic Hyperplasia (BPH) is a noncancerous enlargement of the prostate that puts pressure on the urethra, causing urinary issues. Common symptoms include weakened urine flow, frequent nighttime urination, and difficulty starting urination. Modern treatment options are tailored to individual patient needs and include various key approaches.
Medication
For mild to moderate cases, medications help by relaxing the muscles around the bladder neck, and prostate, relieving pressure on the urethra. Some medications also lower levels of dihydrotestosterone (DHT), a hormone that promotes prostate growth.
Minimally Invasive Surgical Options:
These procedures are ideal for patients who don’t respond to medications or have severe symptoms. They come with shorter hospital stays and faster recovery times, and choices depend on factors like prostate size and the patient’s overall health.
Transurethral Resection of the Prostate (TURP)
This common surgical approach removes excess prostate tissue to relieve urinary symptoms. The surgeon uses a scope to trim the enlarged tissue, often providing patients with immediate relief.
Transurethral Incision of the Prostate (TUIP)
TUIP is a less invasive surgery, effective for
moderate BPH. Small incisions are made to widen the urethra, improving urine flow and easing symptoms.
Transurethral Microwave Therapy (TUMT)
A quick and low-risk procedure, TUMT uses a catheter to deliver thermal energy to shrink prostate tissue. It’s especially helpful for smaller prostates but may require multiple treatments to achieve the desired results.
Holmium Laser Enucleation of the Prostate (HoLEP)
This advanced laser technique precisely removes excess tissue while sealing blood vessels, making it especially useful for larger prostates. HoLEP offers faster recovery and fewer complications than traditional surgery.
Rezum Therapy
Using the thermal energy of water vapor, this non-surgical approach is often completed in a single outpatient visit. It effectively shrinks the prostate, minimizing incisions and hospital time.
Open Surgery
For very large prostates or complex cases, open surgery provides direct access for the partial or full removal of the gland. This procedure involves general anesthesia, a longer hospital stay, and a more extended recovery period.
Prostatitis... Act Fast, Feel Better
Prostatitis is the inflammation of the prostate and can be acute or chronic, often caused by bacterial infections from urine. It affects people of all ages and can lead to painful and frequent urination, as well as pelvic pain. The main causes include:
Bacterial Infections
A major cause of acute prostatitis, as bacteria can reach the prostate through the urinary tract or bloodstream.
Viral Infections
Although less common than bacterial infections, viruses may occasionally lead to prostatitis.
BENIGN PROSTATIC HYPERPLASIA (BPH) IS A NONCANCEROUS ENLARGEMENT OF THE PROSTATE THAT PUTS PRESSURE ON THE URETHRA, CAUSING URINARY ISSUES. COMMON SYMPTOMS INCLUDE WEAKENED URINE FLOW, FREQUENT NIGHTTIME URINATION, AND DIFFICULTY STARTING URINATION. MODERN TREATMENT OPTIONS ARE TAILORED TO INDIVIDUAL PATIENT NEEDS AND INCLUDE VARIOUS KEY APPROACHES.
Blockages
Obstructions in the urinary tract, such as kidney stones or BPH, can increase the risk of prostatitis.
Immune Disorders
Certain immune disorders can cause the immune system to mistakenly attack prostate tissue, leading to chronic inflammation.
Sexual Factors
Some sexual behaviors, like frequent ejaculation or prolonged abstinence, may contribute to inflammation in specific cases.
Early diagnosis of prostatitis is crucial for effective treatment. It allows doctors to customize care for each patient. Completing the treatment is essential to prevent recurrence, as untreated prostatitis can lead to complications like infections or infertility. Regular follow-ups are recommended. Common treatments include:
Antibiotics
The first defense against bacterial infections, with intravenous antibiotics often necessary for severe cases, while oral antibiotics suffice for milder ones.
Alpha Blockers
These medications relax the bladder and prostate muscles, improving urine flow and relieving discomfort.
Pain Relievers
Drugs like acetaminophen or NSAIDs help ease pain and inflammation associated with prostatitis.
Prostate Cancer... Progress in Treatment
Prostate cancer is one of the most treatable cancers when detected early. Regular screenings and an eye on unusual symptoms are essential for timely intervention. Early-stage prostate cancer is usually symptom-free, while more advanced stages may cause urinary issues, bone pain, or unexplained weight loss. Some of the most common symptoms include:
• Difficulty starting urination or weak urine flow
• Frequent urination, particularly at night
• Pain or burning during urination
• Blood in urine or semen
• Pain in the lower back, hips, or pelvic area
• Painful ejaculation
The exact causes of prostate cancer are not fully understood, but several risk factors exist, including age (especially for men over 50) and family history. A high-fat diet and obesity may also increase the risk. Maintaining a healthy lifestyle and having regular screenings can help reduce this likelihood. Diagnosis typically involves a physical exam and PSA blood tests, as elevated PSA levels can indicate prostate cancer, though they may also result from other conditions. A biopsy is usually needed to confirm cancer and assess its type. Various treatment options are available today for prostate cancer.
Surgery
Techniques like radical prostatectomy and laser surgery target the removal of cancerous tissue, aiming to spare healthy tissue.
Radiation Therapy
Radiation can be applied locally or externally to target and destroy cancer cells.
Chemotherapy and Hormone Therapy
These treatments work by slowing or stopping the growth of cancer cells.
Immunotherapy
This approach stimulates the immune system to fight cancer more effectively.
Targeted Therapies
These focus specifically on cancer cells, reducing side effects on surrounding healthy tissue.
Treatment plans are highly personalized, with each one tailored to the cancer stage, tumor size, patient age, and overall health to maximize effectiveness and quality of life.
EARLY DIAGNOSIS OF PROSTATITIS IS CRUCIAL FOR EFFECTIVE TREATMENT. IT ALLOWS DOCTORS TO CUSTOMIZE CARE FOR EACH PATIENT. COMPLETING THE TREATMENT IS ESSENTIAL TO PREVENT RECURRENCE, AS UNTREATED PROSTATITIS CAN LEAD TO COMPLICATIONS LIKE INFECTIONS OR INFERTILITY. REGULAR FOLLOW-UPS ARE RECOMMENDED.
Testicular PRP: A New Hope for Treating Male Infertility
An application that improves the function of sperm-producing cells in the testicles, boosting IVF success rates at Acıbadem Maslak Hospital. PRP (Platelet Rich Plasma) therapy shows promise as an innovative approach to treating male infertility, particularly for men with non-obstructive azoospermia. Testicular PRP injections can enhance sperm concentration, also known as sperm density, which refers to the number of sperm per milliliter of semen.
At Acıbadem Maslak IVF Clinic, testicular PRP is offered as a safe and effective treatment option for male infertility.Infertility may arise from a deficit in either the female or the male. A common cause of infertility in men is azoospermia, characterized by the complete absence of sperm in the ejaculate and is present in around 5%–10% of infertile men.
Currently, the primary treatment for these cases is Micro-TESE, which is a method that involves retrieving sperm directly from the seminiferous tubules of the testis under a microscope in an operating room. Following
the procedure, live sperm cells are separated in the laboratory and, subsequently, injected into the egg using microinjection to ensure fertilization. However, some patients still don’t yield sperm even after repeated Micro-TESE attempts. In these challenging situations, Acıbadem Maslak IVF Clinic offers unique solutions that might enhance sperm quality and quantity, increasing the likelihood of conceiving. PRP application may offer a ray of hope for couples struggling with infertility. To investigate the effects and benefits of PRP on male infertility caused by azoospermia, specialists from Acıbadem’s IVF Department, renowned experts in reproductive medicine and andrology, published the first academic study in this field, achieving promising outcomes.
How PRP Works to Enhance Sperm Producing?
The procedure involves obtaining PRP from the men's own blood through a simple blood draw. After extracting platelet-rich plasma from the blood sample, it is then administered
Testicular PRP: A New Hope for Treating Male Infertility
AT ACIBADEM MASLAK IVF CLINIC, TESTICULAR PRP IS OFFERED AS A SAFE AND EFFECTIVE TREATMENT OPTION FOR MALE INFERTILITY. INFERTILITY MAY ARISE FROM A DEFICIT IN EITHER THE FEMALE OR THE MALE. A COMMON CAUSE OF INFERTILITY IN MEN IS AZOOSPERMIA, CHARACTERIZED BY THE COMPLETE ABSENCE OF SPERM IN THE EJACULATE AND IS PRESENT IN AROUND 5%–10% OF INFERTILE MEN.
Professor Bülent TIRAŞ
into the testis under local or sedation anesthesia, targeting seminiferous tubules or interstitial space. Thus, it can improve sperm concentration, sperm motility, and sperm DNA integrity in men. This innovative technique offers promising prospects for improving IVF outcomes and increasing the chances of successful conception.
Testicular PRP therapy was administered to 135 men included in the study, resulting in positive sperm retrieval rates of 27.5% in patients with one prior failed Micro-TESE procedure and 16.4% in those with two or more failed attempts. IVF outcomes showed fertilization rates of 86.4% and 100.0% in the respective groups, with pregnancy rates of 36.8% and 22.2% per embryo transfer.
REFERENCES
Gudelci T, Cakiroglu Y, Yuceturk A, Batır S, Karaosmanoglu O, Korun ZEU, Tufek I, Kural AR, Tiras B. The effect of intratesticular autologous platelet-rich plasma injection on sperm retrieval rates and in vitro fertilization outcomes in couples with non-obstructive azoospermia. J Obstet Gynaecol Res. 2024 Oct;50(10):1977-1984. doi: 10.1111/jog.16093. Epub 2024 Sep 20. PMID: 39305061.
Why are more young people getting cancer? What to know as cases rise
It’s a mystery doctors and scientists have yet to solve: More younger adults are getting diagnosed with cancer. The number of early onset cancer cases — those that occur in adults under age 50 — is rising by 1% to 2% annually, according to the American Cancer Society. An analysis of global health data published in the journal BMJ Oncology predicts a 30% jump in early onset cancers between 2019 and 2030. Meanwhile, celebrity cancer cases — including actor Chadwick Boseman’s death from colon cancer at age 43, or the cancer diagnosis at 42 of Catherine,
Princess of Wales — have put a spotlight on young people facing the disease.
Oncologists at the University of Chicago Medicine Comprehensive Cancer Center say they’re seeing the increase firsthand, and that they are treating more patients in their 30s and 40s in many cancers, including breast, colorectal, and head and neck cancers.
What factors are causing cancer in young people?
Scientists and researchers are still searching for a specific culprit.
ONCOLOGISTS AT THE UNIVERSITY OF CHICAGO MEDICINE COMPREHENSIVE CANCER CENTER ARE TREATING MORE PATIENTS IN THEIR 30S AND 40S IN MANY CANCERS
“We have yet to identify any singular reason, although it’s likely related to a multitude of factors — possibly including lifestyle or environmental ones,” said UChicago Medicine adult and pediatric oncologist Adam DuVall, MD, MPH.
Some possible reasons include:
• Chronic inflammation: The body’s response to injuries and “invaders” can be caused by low physical activity, obesity, chronic stress, prolonged infections or chronic exposure to toxins.
• Later-in-life birth and/or having fewer children: Reproductive factors can lead to a slightly higher breast, ovarian or endometrial cancer risk.
• Gut microbiome changes: When this delicate network of bacteria is thrown off balance — possibly by processed foods, microplastics or other substances — it could be easier for tumors to grow.
• Healthcare disparities: Inequities in care can limit access to healthy food and timely treatment.
Cancer prevention in young people: 6 simple strategies that can help Young people diagnosed with cancer often fall below the minimum recommended age for screenings that can catch their disease early, said UChicago Medicine gynecologic oncologist Nita Karnik Lee, MD, MPH.
it’s more important than ever for young adults to add cancer prevention measures to their todo lists. Three key steps can help:
1. Know the screening, prevention and risk reduction options suitable for your age group
2. Learn about your family’s cancer history
3. Identify the health symptoms that should warrant an immediate visit to your doctor
Early detection offers the best chance for survival. While nothing fully protects against cancer, oncologists from the University of Chicago Medicine shared several ways for young adults to stay vigilant:
1. See a primary care physician annually
An urgent care facility is fine for immediate care, but it’s also important to see a primary care physician. Go once a year for a physical, even if you’re not sick. Routine tests to measure blood pressure, heart rate and weight — as well as physical exams and blood tests — provide a wealth of data over time. These visits also help build a personal connection.
“Talking to a doctor you’ve known for four, five years or longer about a new complaint is different than talking to somebody at a random urgent care who you just met,” DuVall said. “Your doctor knows you and won’t be quick to dismiss your concerns.”
2. Learn your family’s medical history — and share it with your doctor
If possible, find out who in your family had cancer, what type and at what age. That information can be valuable — especially for gauging your risks of some of the more hereditary certain cancers, such as breast, ovarian, colon or prostate cancer. About 5% to 10% of all cancers are thought to involve genetics inherited from a parent, according to the National Cancer Institute.
“Your family history may modify what your screening regimens are,” Lee said. “Your doctor may say, ‘You know what? Your mom was 45 when she had colon cancer, so you need to start your colon cancer screening at a younger age or more frequently.’ If you don’t share that history, doctors may not know how to best tailor their recommendations for you.”
3. Consider genetic testing
If you do have a strong family history of cancer,
MPH Assistant Professor of Medicine (Hematology and Oncology)
MPH Associate Professor of Obstetrics and Gynecology
Associate Director, University of Chicago
Comprehensive Cancer Center
Community Outreach and Engagement
Adam DuVall, MD
Nita Karnik Lee, MD
or if you want more information about your health, ask your doctor about genetic testing. This can involve a blood, saliva or cheek swab test. The results can help you understand your inherited cancer risks and if more regular screenings are necessary. A genetic counselor can help to construct a family tree and better assess risks or need to get testing done.
Over-the-counter genetic tests are not particularly reliable, Lee said. She recommends UChicago Medicine’s Comprehensive Cancer Risk and Prevention Clinic, which specializes in genetic testing and counseling.
“Not everybody who has a family history should automatically get a genetic test,” said Lee, who is also Associate Director for Community Outreach and Engagement at the UChicago Medicine Comprehensive Cancer Center. “There are a lot of nuances and medical and family history will be reviewed to decide if testing — and which test — would be best and whether a family member might want to undergo initial testing.”
There are disparities in genetic testing, Lee said.
“Minority patients are less likely to get appropriate testing based on family history alone, so we want to be sure young people ask and know about their cancer history on both sides of the family,” she said.
If genetic testing does uncover a mutation, that can put you at a higher-than-average risk for certain cancers. This may change recommendations for the age to start screening, or the type or frequency of a screening exam.
4. Get age-appropriate cancer screenings and an HPV vaccine Universal prevention starts early with a vaccination for human papillomavirus (HPV). The vaccine is recommended for boys and girls ages 9 to 26, and it can be given up until age 45. It has been shown to prevent several HPV-related cancers, including cervical, vulvar/ vaginal, anal and oropharyngeal.
“The best thing is to get an HPV vaccine as soon as you’re eligible. You want it before you have exposure to HPV,” which is transmitted through sexual (genital skin to skin) contact, even if the infected person has no symptoms, said UChicago Medicine head and neck surgical oncologist Nishant Agrawal, MD.
For people who have an average risk of cancer, here are other screening milestones to know:
• Starting at age 25: People with a cervix should get an HPV test every five years, even if they’ve been vaccinated for HPV.
• At age 40: Begin receiving mammograms and talk to your doctor about the best screening plan.
• At age 45: Start testing for colon cancer with a colonoscopy or stool testing.
• At age 45: Men at high risk of prostate cancer (including Black men and those with close family members who had the disease before age 65) should talk to their doctors about screening.
• At age 50: Receive annual low-dose CT scans for lung cancer if you have a smoking history of 20 pack years, currently smoke, or have quit within the last 15 years.
5. Eat healthy foods, don’t smoke, and exercise regularly
Nishant Agrawal MD Professor of Surgery
Chief, Section of Otolaryngology-Head and Neck Surgery
There’s a reason every doctor recommends this. Poor eating, excessive alcohol use, smoking and an inactive lifestyle are proven to trigger — or worsen — almost every disease.
At least 18% of all cancers diagnosed in the U.S. are related to high body fat, physical inactivity, alcohol consumption and/ or poor nutrition, according to the American Cancer Society.
6. Pay attention to unusual symptoms that won’t go away
A new symptom might not indicate cancer, but it’s important to seek medical care to gain a better understanding of the situation. If you experience any of the following, call your doctor:
• Blood in the stool or rectal bleeding
• Changes in bowel or bladder habits
• Changes in your breasts
• Difficulty swallowing
• Irregular vaginal bleeding
• Lumps on the body
• New abdominal pain or pelvic pain
• New swollen glands
• Persistent cough
• Skin changes or irregular moles
“If there’s something different that’s happening, you should ask your doctor, ‘What tests can I do to help me figure out if this is something more serious?’ Be sure to advocate for yourself if something does not seem right to you,” Lee said.
HPV VACCINE IS RECOMMENDED FOR BOYS AND GIRLS AGES 9 TO 26, AND IT CAN BE GIVEN UP UNTIL AGE 45.
Mrs.
Diana Boudargham Tannoury... A Survivor's Mission
President & Founder of Diana Boudargham Tannoury Women's Cancer Foundation
Mrs. Diana Boudargham Tannoury's initiative to establish a specialized women's cancer institute at Hotel Dieu de France Hospital marks a significant step towards providing comprehensive healthcare for those affected by this disease.
Diana Boudargham Tannoury Foundation has achieved a significant milestone with the inauguration of its women's cancer institute at Hotel Dieu de France. This world-class facility is poised to become a leading center for cancer care, offering innovative treatments, cuttingedge research, and a holistic approach to patient well-being. As a survivor of ovarian cancer herself, Mrs. Tannoury recognized the suffering of these patients and decided to take proactive
measures to support cancer patients in Lebanon. In this interview, "Hospitals" magazine will enlighten Mrs. Tannoury's story and explain how she transformed her personal experience with the disease into a driving force in establishing an institute aimed at saving women's lives.
What inspired you to establish a women's cancer institute after your personal experience with the disease?
In December of 2021, I was diagnosed with stage 3C Ovarian Cancer that had started nine months earlier and appeared in an MRI, which did not show any abnormalities, as two normal simple adnexal cysts, one in each ovary.
I was blessed to be operated on at the
WHEN ONE IS SO CLOSE TO LOSING LIFE, EVERYTHING BECOMES A BLESSING, EVEN PAIN. PAIN BECAME MY FRIEND, AND IT WAS A REMINDER TO BE GRATEFUL THAT I WAS STILL ALIVE AND CAPABLE OF FEELING IT.
INTERVIEWS
Hotel Dieu de France (HDF) hospital during a seventeen-hour debulking surgery by Professor David Attallah, Head of Gynecologic Oncology and Breast Surgery Unit, Professor Riad Sarkis, Digestive and Endocrine Surgery and the rest of their colleagues, as well as followed up by Professor Fadi Nasr, Chief of the Oncology Department. An ovarian cyst is the first sign of Ovarian Cancer, and if it is detected early enough and followed up with the proper exams and medical protocol, a woman’s life can be saved. My case was detected early at the precancerous stage but was not followed up by the oncologist gynecologist at a non-university hospital in Beirut where my cysts were first discovered, nine months later, pain in my pelvic area led me to do another MRI and to discover my advanced stage of cancer.
After the surgery, in recovery at Hotel Dieu, I knew that God had given me a mission. A pre-cancerous or even cancerous cyst does not have to lead to a life-threatening diagnosis, and I pledged to prevent as many women as possible from living through the ordeal of cancer. I created a Women's Cancer Foundation
in my name, with a Women's Cancer Institute at Hotel Dieu De France, to raise awareness about Ovarian Cancer as well as breast cancer, and other types of gynecological cancers and to support cancer patients through this painful and life-transforming journey.
While I was at HDF, I had a friend who was also there fighting her battle with ovarian cancer and who eventually succumbed to it. Her name is Nicole Zakhour. Her strength and faith inspired me, and I promised myself that if I made it out alive, I would fight for all those who had left us and for every family member who had lost a loved one to cancer to save as many lives as possible.
What were the most significant challenges you faced during your treatment journey, and how did this experience change your perspective on life?
I woke up after the debulking surgery at Zero Residue, which is lifesaving. The journey was long and challenging; halfway through my chemotherapy, my intestine ruptured, I was rushed into the operating room, and as I closed
I CREATED A WOMEN'S CANCER FOUNDATION IN MY NAME, WITH A WOMEN'S CANCER INSTITUTE AT HOTEL DIEU DE FRANCE, TO RAISE AWARENESS ABOUT OVARIAN CANCER AS WELL AS BREAST CANCER, AND OTHER TYPES OF GYNECOLOGICAL CANCERS AND TO SUPPORT CANCER PATIENTS THROUGH THIS PAINFUL AND LIFE-TRANSFORMING JOURNEY.
Rector of Saint Joseph University and Chairman of the Board of Hôtel-Dieu de France Father Professor Salim Daccache, Minister of Public Health Dr. Firas Abiad, Prime Minister Najib Mikat, President of the Foundation Diana Bou Dargham Tannoury, General Director of the (USJHDF) Hospitals Network Nassib Nasr and Director of the Women’s Cancer Center Professor David Attallah (left to right)
my eyes, I surrendered to God’s Will as well as to the hands of two skilled surgeons in digestive surgery, Professor. Roger Noun and Dr. Ghassan Chakhtoura. After this surgery, a stoma was placed on my intestine to protect it during the rest of my chemo sessions, and I spent a month in the ICU fighting infections. The stoma wound was painful, and I suffered for over a year while I was fragile at 40kgs, barely able to walk, still recovering from my debulking surgery and continuing my treatments.
When one is so close to losing life, everything becomes a blessing, even pain. Pain became my friend, and it was a reminder to be grateful that I was still alive and capable of feeling it. When one is helpless and sick, one realizes the importance of family. The love my husband, Bernard, and my three boys, Georges, Jad, and Andrew, surrounded me with became my driving force to survive. The support I received from my sister-in-law Nathalie and my friends, who know who they are, as well as my parents and brothers carried me through.
All through this journey, from the moment of diagnosis, I had received many signs from
God, and when the doctors told me that it was a miracle I had survived the ruptured intestine, I smiled. This experience took my faith to a new level and confirmed what I had felt in my heart: I had a mission to continue.
Based on your personal experience, why is community awareness about cancer, especially women's cancers, so important, particularly during October, which is Breast Cancer Awareness Month? By the time of diagnosis, 60 percent of ovarian cancer cases are at stage 3 and have a 5-year survival rate of 40 percent; this means cancerous cells have spread from the ovaries or fallopian tubes to nearby tissues, such as the abdominal cavity or lymph nodes. We need to reach these women at the first sign of a cyst, which an oncologist-gynecologist should closely monitor. Even after an MRI is clear, a cyst can be pre-cancerous or develop into cancer, and it should only be removed by a specialist in case it ruptures. A gynecologist should be aware of this and refer the patient to an oncologist gynecologist for follow-up, removal of cysts, or
I WAS BLESSED TO BE OPERATED ON AT THE HOTEL DIEU DE FRANCE (HDF) HOSPITAL DURING A SEVENTEENHOUR DEBULKING SURGERY BY PROFESSOR DAVID ATTALLAH, HEAD OF GYNECOLOGIC ONCOLOGY AND BREAST SURGERY UNIT, PROFESSOR RIAD SARKIS, DIGESTIVE AND ENDOCRINE SURGERY AND THE REST OF THEIR COLLEAGUES, AS WELL AS FOLLOWED UP BY PROFESSOR FADI NASR, CHIEF OF THE ONCOLOGY DEPARTMENT.
even the removal of the ovaries.
Patients should be careful about whom they are being referred to because only a few capable specialists are left in Lebanon. Even though I had initially seen an oncologistgynecologist at another hospital, he had failed to follow up on the cysts through the correct protocol, and what could have been a straightforward procedure nearly cost me my life. It is thus important during October, which is breast cancer month, to remember to follow up on mammography and breast and gynecological ultrasounds. Early cancer detection is life-saving.
What are the most significant services for cancer patients, starting from diagnosis to treatment? Can you tell us more about the doctors and medical staff working at the institute and their qualifications? A whole support system has been put in place to follow patients in need from diagnosis through surgeries, adjuvant treatments, and medical and psychological assistance. We inaugurated the Women’s Cancer Institute on September 16th. Our vision is to transform the landscape of Women’s Healthcare in Lebanon through awareness programs for pre-cancer
and early cancer detection, prevention, surgical interventions, medical support and research, women’s empowerment, and high-quality care.
After my debulking surgery in December 2021, we started supporting Women's Cancer patients at Hotel Dieu through a donation of the Rubina system with 4K resolution and fluorescence-guided surgery, which creates a clear view of details and helps detect early signs of endometrial, cervical, and ovarian cancer as well as lymph nodes in case of involvement. This is a first step in early diagnosis following an MRI, but it also made me realize that although this machine is beneficial in early detection and operation for early-stage ovarian cancer and other gynecological cancers, many women cannot afford to benefit from it. With the support of CEO of HDF Mr. Nasib Nasr and the Hotel Dieu Management and doctors, we have been helping women with cancer for the past two years by funding surgeries and medical treatments.
In the gynecologic oncology and breast surgery unit department, two trained gynecologic oncologists are highly qualified to treat gynecologic and breast cancers. The Department performs all kinds of surgeries, starting from minimally invasive surgeries with
IN THE GYNECOLOGIC ONCOLOGY AND BREAST SURGERY DEPARTMENT, TWO TRAINED GYNECOLOGIC ONCOLOGISTS ARE HIGHLY QUALIFIED TO TREAT GYNECOLOGIC AND BREAST CANCERS. THE DEPARTMENT PERFORMS ALL KINDS OF SURGERIES, STARTING FROM MINIMALLY INVASIVE SURGERIES WITH SENTINEL LYMPH NODES FOR ENDOMETRIAL AND CERVICAL CANCERS. USING THE 4K ICG TECHNOLOGY, MORE THAN 95% OF OUR UTERINE SURGERIES ARE DONE WITH MINIMALLY INVASIVE ROOTS.
sentinel lymph nodes for endometrial and cervical cancers. Using the 4K ICG technology, more than 95% of our uterine surgeries are done with minimally invasive roots. The department is a referral institute for vulvar cancers with all modalities of reconstruction and de-escalation with sentinel lymph nodes using the ICG or the technetium. As a European Society of Gynecological Oncology (ESGO) accredited center, the department is the first ESGO-accredited center in the Middle East region. Breast surgeries are performed using high technology and experience with the oncoplastic techniques and sentinel lymph nodes, along with supra radical surgeries in advanced cases when needed.
Why did you choose this hospital based on the recently opened institute at Hotel Dieu de France Hospital? What sets it apart?
I selected Hotel Dieu de France due to the expertise of Dr. David Atallah, a renowned professor of obstetrics and gynecology and the chairman of the department, including the gynecologic oncology and breast surgery unit, where you can find a team of skilled professionals and state-of-the-art facilities, making it a leading research institution in the field. Dr. Atallah, who played a crucial role in my recovery, holds leadership positions in various medical organizations; he is president of the Lebanese Society of Obstetrics and Gynecology, a board member of the International Gynecological Society (IGS) as well as Secretary
General of the Middle East and Mediterranean Association of Gynecologic Oncologist (Memago). HDF recently acquired a new MRI machine, a 1.5 Tesla Voyager from GE, and a new CT scan machine, an AQUILION from Canon. These advanced machines are a valuable asset to the radiology department at HDF, led by Dr. Kamal Hachem, Head of the Radiology Department. They will enable earlier detection and more accurate diagnoses, leading to improved patient outcomes. I chose HDF because of the emotional support that the doctors, nurses, and staff gave me. Patients are not just numbers; it is not a hospital that wants to profit at the cost of human life. Its humane environment sets it apart from some other institutions.
Our biggest challenge today is to provide women's cancer patients with expensive drugs that are no longer available at the Ministry of Health due to the economic crisis and that can prolong their remission period and even save their lives. One of these drugs is Olaparib, which is a parp inhibitor and works on women who have a mutation in their ovarian cancer tumor or who have a genetic mutation (brca 1 or brca 2). Olaparib improves the 5-year survival rate of women with stage 3 ovarian cancer to 67 percent. I can afford to buy this drug that will keep me in remission until I am out of danger, but what about the others? I had cancer like many other women; today, in Lebanon, a high percentage of these women do not have access to early cancer diagnosis through MRIs, lifesaving surgeries, and medical treatments.
This is how my mission began.
PROFESSOR FADI NASR
PROFESSOR FADI NASR, HEAD OF THE ONCOLOGY DEPARTMENT AT HDF, DEDICATED HIS CAREER TO SERVING CANCER PATIENTS AND SUPPORTING THOSE WITH LIMITED RESOURCES. HE RECENTLY PASSED AWAY AFTER A LONG BATTLE WITH COLON CANCER. I WILL NEVER FORGET HOW HE USED TO ENTER MY HOSPITAL ROOM WHILE HE WAS HIMSELF UNDERGOING CHEMOTHERAPY TREATMENTS TO ENCOURAGE ME WITH HIS STRENGTHENING WORDS AND HIS BEAUTIFUL SMILE. HE WAS A MAN FULL OF FAITH, LIGHT AND LOVE. HIS LEGACY WILL LIVE ON THROUGH THE WOMEN'S CANCER INSTITUTE.
OUR BIGGEST CHALLENGE TODAY IS TO PROVIDE WOMEN'S CANCER PATIENTS WITH EXPENSIVE DRUGS THAT ARE NO LONGER AVAILABLE AT THE MINISTRY OF HEALTH DUE TO THE ECONOMIC CRISIS AND THAT CAN PROLONG THEIR REMISSION PERIOD AND EVEN SAVE THEIR LIVES
The Difference Between ICSI and IVF: Modern Medical Solutions for Delayed Pregnancy
Dr. Ahmed Khalfallah, Consultant Obstetrics Gynecology-IVF at Al-Ahli Hospital/Qatar
Delayed pregnancy can be a significant challenge for many couples. Thanks to advances in medical technology, several solutions are now available to help couples achieve their dream of parenthood. Among the most well-known techniques are Intracytoplasmic Sperm Injection (ICSI) and In Vitro Fertilization (IVF).
While both techniques involve fertilization outside the womb in a laboratory setting, there are key differences between them, particularly in the method of fertilization. This article will explore the differences between ICSI and IVF and how to choose the most suitable option based on individual circumstances.
What is the Difference Between ICSI and IVF?
Both ICSI and IVF involve extracting eggs from the woman and fertilizing them in a laboratory, followed by transferring the resulting embryos to the woman's uterus. However, the primary distinction lies in the fertilization process itself.
In traditional IVF, multiple sperm are placed alongside the eggs in a laboratory dish, and fertilization is allowed to occur naturally without direct intervention. The strongest sperm will fertilize the egg, mimicking the natural fertilization process that happens inside the body. In contrast, ICSI is used in cases where there is significant male infertility. In this technique, a single sperm is selected and directly injected into the egg using a fine needle. This ensures that fertilization occurs, especially in cases where the sperm may not be capable of penetrating the egg naturally, thus improving the chances of fertilization.
Which is Better?
Each technique has advantages and is used depending on the couple's condition.
1. IVF (In Vitro Fertilization):
• IVF is often the first-line treatment in most cases of infertility, particularly if the issue lies with the female or in cases of unexplained infertility.
• IVF is favored because it is less invasive compared to ICSI and typically less expensive.
• It is ideal if the male partner has normal sperm parameters and there are no significant issues with sperm count, quality, or motility.
2. ICSI (Intracytoplasmic Sperm Injection):
• ICSI is the preferred option in cases of severe male infertility, such as low sperm count, poor motility, or abnormal sperm shape.
• In ICSI, the best sperm is carefully selected and injected directly into the egg, which increases the chances of
ICSI IMPROVES THE CHANCES OF SUCCESSFUL FERTILIZATION BY BYPASSING THE SPERM’S NATURAL BARRIERS TO FERTILIZATION. HOWEVER, IF THE MALE SPERM PARAMETERS ARE NORMAL, IVF IS TYPICALLY THE FIRST RECOMMENDED TREATMENT DUE TO ITS LESS INVASIVE NATURE AND LOWER COST.
fertilization in cases where natural fertilization may not be successful.
• ICSI is usually recommended if previous IVF attempts have failed or if there are known issues with sperm quality.
How Are ICSI and IVF Performed?
The basic steps for both ICSI and IVF are similar, with only the fertilization process differing:
1. Ovulation Stimulation
The woman receives hormone medications for 7-14 days to stimulate the ovaries to produce more eggs. Once the eggs are mature, an injection (trigger shot) is administered to prepare them for retrieval.
2. Egg Retrieval
The mature eggs are collected from the ovaries using a thin needle under sedation, ensuring the woman feels no pain during the procedure. The retrieved eggs are then prepared for fertilization.
3. Fertilization
• In IVF, sperm from the male partner is placed in the same laboratory dish as the eggs, allowing fertilization to occur naturally.
• In ICSI, the best sperm is selected and injected directly into the egg using a fine needle.
4. Embryo Development
In the incubator, the fertilized eggs are left to develop into embryos over the next 2-5 days.
5. Embryo Transfer
If fertilization is successful and the embryos develop well, one or more embryos are transferred to the woman’s uterus using a thin tube. This step usually doesn’t require anesthesia.
6. Pregnancy Test
Two weeks after the embryo transfer, a pregnancy test is conducted to determine whether the treatment was successful.
When Should You Choose ICSI?
ICSI is considered the best option in cases of
severe male infertility, where there are:
• A very low sperm count.
• Poor sperm motility.
• Abnormalities in sperm shape.
• Previous IVF cycles have failed. ICSI improves the chances of successful fertilization by bypassing the sperm’s natural barriers to fertilization. However, if the male sperm parameters are normal, IVF is typically the first recommended treatment due to its less invasive nature and lower cost.
Fertility Center and IVF at Al Ahli Hospital
At Al Ahli Hospital, we are committed to offering the best and most advanced medical techniques to address fertility challenges and delayed pregnancy. Our team of specialists conducts comprehensive assessments for both partners to determine the underlying causes of delayed pregnancy and work with the couple to choose the most appropriate treatment, whether that’s IVF or ICSI. We use state-of-the-art laboratory technologies to ensure the highest success rates, all while providing a safe, comfortable, and private environment for couples. Our expert team is always available to answer any questions and guide you through the process to make the best decision for your unique situation.
Conclusion
The difference between ICSI and IVF lies primarily in the method of fertilization. While IVF is the go-to option in most infertility cases, ICSI is the preferred choice in severe cases of male infertility. With careful medical assessment, a fertility specialist can determine the most suitable method for each couple, ensuring the best possible outcome. If you face challenges in conceiving, we invite you to visit Al Ahli Hospital’s Fertility Center, where our team of experts is ready to assist you with the latest reproductive techniques and personalized care. Together, we can help you move one step closer to achieving your dream of parenthood.
IN TRADITIONAL IVF, MULTIPLE SPERM ARE PLACED ALONGSIDE THE EGGS IN A LABORATORY DISH, AND FERTILIZATION IS ALLOWED TO OCCUR NATURALLY WITHOUT DIRECT INTERVENTION. THE STRONGEST SPERM WILL FERTILIZE THE EGG, MIMICKING THE NATURAL FERTILIZATION PROCESS THAT HAPPENS INSIDE THE BODY. IN CONTRAST, ICSI IS USED IN CASES WHERE THERE IS SIGNIFICANT MALE INFERTILITY
The Future of Medicine: A Comprehensive Look at Longevity, Lifestyle
Medicine,
and AI in Medical Education
Dr. Edyta Skibinska, Assistant Professor of Hospital and Healthcare Management at American University in the Emirates
The healthcare landscape is undergoing a profound transformation, driven by the convergence of several cutting-edge fields: longevity science, lifestyle medicine, and artificial intelligence. This shift is not merely a trend but a necessary evolution in response to the changing health challenges of the 21st century. As chronic diseases reach epidemic proportions and life expectancy continues to rise, the traditional reactive approach to medicine is proving insufficient. Instead, a proactive, holistic, and technologically enhanced approach is needed to address the complex health issues of our time.
This article delves deep into the integration of longevity science, lifestyle medicine, and AI into medical education and practice, drawing insights from Dr. Edyta Skibinska, a leading expert in the field and awarded mastermind in lifestyle medicine and longevity. We will explore how these disciplines reshape our understanding of health and disease and how they can be effectively incorporated into medical curricula to prepare the next generation of healthcare professionals. Dr. Edyta's pioneering work and recognition as a mastermind in these areas provide a solid foundation for understanding the transformative potential of these integrated approaches in medical education and practice.
The Paradigm Shift in Healthcare
The global healthcare landscape is experiencing a seismic shift, driven by an alarming increase in lifestyle-related chronic diseases and an aging population. Conditions such as diabetes, heart disease, and obesity have now become global epidemics. According to the World Health Organization, chronic diseases are responsible for around 71% of all deaths globally, with this figure expected to rise in the coming decades.
Simultaneously, advancements in medical science and public health measures have led to unprecedented increases in life expectancy. However, this longevity often comes at the cost of increased years lived with disability or chronic illness. This phenomenon has given rise to a new focus in healthcare: extending not just lifespan, but "healthspan" - the number of years lived in good health.
Traditional medical education, with its focus on treating acute illnesses and managing chronic diseases, is ill-equipped to address these new challenges. The current model, largely reactive and disease-focused, fails to adequately address the root causes of many modern health issues. This is where the integration of longevity science and lifestyle medicine becomes crucial.
Longevity science explores the biological mechanisms of aging and potential interventions to slow or reverse these processes. It seeks to understand why we age at a cellular and molecular level and how to leverage this knowledge to extend healthy life. On the other hand, lifestyle medicine utilizes evidence-based lifestyle interventions to prevent, treat, and often reverse chronic diseases. It recognizes that daily habits and environmental factors largely influence many of the most prevalent health issues today.
Integrating these fields into medical education represents a paradigm shift from a disease-centered model to a healthcentered one. It emphasizes prevention over cure, optimization over management, and views health as a positive state to be actively maintained rather than merely the absence of disease. This new paradigm of healthcare is not about replacing traditional medicine, but enhancing it with a more holistic, preventive, and personalized approach.
THE GLOBAL HEALTHCARE LANDSCAPE IS EXPERIENCING A SEISMIC SHIFT, DRIVEN BY AN ALARMING INCREASE IN LIFESTYLERELATED CHRONIC DISEASES AND AN AGING POPULATION. CONDITIONS SUCH AS DIABETES, HEART DISEASE, AND OBESITY HAVE NOW BECOME GLOBAL EPIDEMICS. ACCORDING TO THE WORLD HEALTH ORGANIZATION, CHRONIC DISEASES ARE RESPONSIBLE FOR AROUND 71% OF ALL DEATHS GLOBALLY, WITH THIS FIGURE EXPECTED TO RISE IN THE COMING DECADES
The Role of Artificial Intelligence in Preventive Medicine
Artificial Intelligence (AI) is rapidly becoming an indispensable tool in healthcare, with its potential particularly evident in the realm of preventive medicine.
As we move towards a more proactive and personalized approach to health, Artificial Intelligence (AI) offers unprecedented capabilities in predicting, preventing, and managing health issues.Integrating AI education into medical curricula is crucial to prepare future healthcare professionals for this technological revolution. Let's explore the key areas where AI is revolutionizing healthcare through six main areas:
1. Predictive Analytics
• Uses patient data to predict disease risks
• Helps doctors make more informed decisions using machine learning models
2. Personalized Medicine
• Tailors treatments based on genetics and lifestyle
• Enables customized medication and treatment plans
3. Early Disease Detection
• Excels in analyzing medical images (X-rays, scans)
• Often matches or exceeds human expert performance in detection
4. Lifestyle Monitoring
• Uses wearables and apps to track health metrics
• Provides real-time health recommendations
5. Drug Discovery
• Speeds up new treatment identification
• Helps optimize clinical trials and predict drug interactions
6. Ethical Considerations
• Addresses privacy concerns
• Focuses on maintaining human oversight
• Deals with algorithmic bias
Medical students need training in all these areas to effectively use Artificial Intelligence tools while maintaining critical thinking and clinical judgment. The goal is to use AI to augment, not replace, medical expertise.
Challenges in Implementing Educational Changes
While the integration of longevity science, lifestyle medicine, and AI into medical education holds immense promise, it also presents significant challenges.
Addressing these challenges is crucial for the successful implementation of these educational changes. Let's explore these obstacles in detail:
1. Time Constraints in Medical Curricula:
Medical school curricula are already packed with essential knowledge and skills that future doctors need to master.
Adding new content areas like longevity science, lifestyle medicine, and AI inevitably puts pressure on existing time allocations. Potential solutions:
• Integrating new content into existing courses rather than creating separate modules.
• Utilizing flipped classroom models and e-learning platforms to maximize inperson instruction time.
• Extending the duration of medical education or restructuring the curriculum to allow for more comprehensive coverage.
2. Resistance to Change
Medical education, like many established systems, can be resistant to change. Faculty members, administrators, and even students may hesitate to embrace new paradigms that challenge traditional medical models. Addressing this challenge:
• Providing robust evidence of the effectiveness of these new approaches in improving patient outcomes
• Offering faculty development programs to help educators integrate new content into their teaching
3. Faculty Training
Many current medical educators may not have extensive knowledge or experience in longevity science, lifestyle medicine, or AI. Training faculty members in these rapidly evolving fields is crucial for effective implementation. Strategies for faculty development:
• Organizing workshops, seminars, and continuing education programs focused on these new areas
• Encouraging interdisciplinary collaboration with experts in relevant fields
• Providing resources and support for faculty to engage in research and practice in these areas
4. Skepticism About Efficacy:
There may be skepticism within the medical community about the efficacy of lifestyle interventions compared to pharmaceutical treatments, or concerns about the reliability of AI in clinical decision-making. Addressing skepticism:
• Emphasizing evidence-based approaches and highlighting high-quality research demonstrating the effectiveness of lifestyle medicine and AI applications
• Encouraging critical thinking and scientific evaluation of all medical interventions, both traditional and new
• Providing opportunities for hands-on experience with lifestyle interventions and AI tools to demonstrate their practical value
5. Shift Towards Holistic Approaches
Moving from a purely physical, symptom-based approach to one that considers the whole person - including mental and emotional health - requires a significant shift in thinking and practice. Facilitating this shift:
• Integrating principles of holistic health throughout the curriculum
• Providing training in communication skills and empathy to help future doctors address all aspects of patient health
• Incorporating case studies and simulations that emphasize the
TRADITIONAL MEDICAL EDUCATION, WITH ITS FOCUS ON TREATING ACUTE ILLNESSES AND MANAGING CHRONIC DISEASES, IS ILL-EQUIPPED TO ADDRESS THESE NEW CHALLENGES. THE CURRENT MODEL, LARGELY REACTIVE AND DISEASEFOCUSED, FAILS TO ADEQUATELY ADDRESS THE ROOT CAUSES OF MANY MODERN HEALTH ISSUES. THIS IS WHERE THE INTEGRATION OF LONGEVITY SCIENCE AND LIFESTYLE MEDICINE BECOMES CRUCIAL
interconnectedness of physical, mental, and emotional health
6. Keeping Pace with Rapid Technological Advancements
The field of Artificial Intelligece in healthcare is evolving rapidly, making it challenging to keep educational content up-to-date. Strategies for staying current:
• Developing flexible, modular curricula that can be easily updated
• Fostering partnerships with technology companies and research institutions to stay abreast of the latest developments
• Encouraging lifelong learning and providing resources for continuous education post-graduation
7. Ethical and Legal Considerations
The use of AI in healthcare and the emphasis on lifestyle factors raise new ethical and legal
questions that need to be addressed in medical education. Addressing these issues:
• Developing comprehensive courses on medical ethics that include AI and lifestyle medicine considerations
• Engaging legal experts to help design curriculum components addressing the legal aspects of these new approaches
• Encouraging ongoing dialogue and debate about the ethical implications of new technologies and approaches in medicine
By proactively addressing these challenges, medical education can evolve to better prepare future healthcare professionals for the changing landscape of medicine.
This evolution is essential for creating a more preventive, personalized healthcare system, and effective in addressing the health challenges of the 21st century.
LONGEVITY SCIENCE EXPLORES THE BIOLOGICAL MECHANISMS OF AGING AND POTENTIAL INTERVENTIONS TO SLOW OR REVERSE THESE PROCESSES. IT SEEKS TO UNDERSTAND WHY WE AGE AT A CELLULAR AND MOLECULAR LEVEL AND HOW TO LEVERAGE THIS KNOWLEDGE TO EXTEND HEALTHY LIFE. ON THE OTHER HAND, LIFESTYLE MEDICINE UTILIZES EVIDENCEBASED LIFESTYLE INTERVENTIONS TO PREVENT, TREAT, AND OFTEN REVERSE CHRONIC DISEASES. IT RECOGNIZES THAT DAILY HABITS AND ENVIRONMENTAL FACTORS LARGELY INFLUENCE MANY OF THE MOST PREVALENT HEALTH ISSUES TODAY.
How Can Insomnia Be Treated?
Dr. Abeer Eissa, Consultant Psychiatrist at Al-Ahli Hospital/Qatar
Insomnia is a common issue that many people experience in their daily lives. This article will explore how to manage insomnia, from improving sleep habits to modern medical treatments.
Overcoming Insomnia through Healthy Sleep Habits
To begin, adopting healthy sleep habits can significantly improve sleep quality. Some tips include:
• Going to bed and waking up at the same time every day.
• Ensuring your bedroom is comfortable, with a suitable temperature and dim lighting.
• Avoiding electronic devices before bedtime.
• Steering clear of caffeine and smoking in the evening.
• Reducing fluid intake before bed to prevent frequent waking.
• Engaging in regular exercise during the day (at least 5-6 hours before bedtime).
Cognitive Behavioral Therapy (CBT)
Cognitive Behavioral Therapy (CBT) is one of the most effective non-medical treatments for insomnia. It helps to change negative thoughts and habits related to sleep. This therapy involves:
• Addressing negative sleep-related thoughts.
• Following a healthy sleep routine under expert guidance.
• Learning relaxation techniques, such as breathing exercises and meditation.
• Associating the bed with sleep only, avoiding other activities that may interfere with rest.
The Role of Medications in Treating Insomnia
Sleep medications are typically used for shortterm relief and fall into two categories:
• Over-the-counter medications, such as antihistamines and melatonin, can temporarily improve sleep.
• Prescription medications, such as benzodiazepines and non-benzodiazepine sedatives, are used in more severe cases under medical supervision.
Consulting a doctor
It is essential to consult a doctor before using any medication, even if it is over the counter, as some medications may not suit everyone. At Al Ahli Hospital, we offer modern therapeutic sessions to help individuals overcome insomnia, with personalized consultations to ensure the best outcomes.
COGNITIVE BEHAVIORAL THERAPY (CBT) IS ONE OF THE MOST EFFECTIVE NON-MEDICAL TREATMENTS FOR INSOMNIA. IT HELPS TO CHANGE NEGATIVE THOUGHTS AND HABITS RELATED TO SLEEP.
"GHA brings a wealth of expertise and specialized knowledge to help healthcare organizations develop robust medical travel strategies that are sustainable and patient-focused."
Renée-Marie Stephano, Global Healthcare Accreditation’s Chief Executive Officer
HOSPITALS Magazine is excited to interview Renée-Marie Stephano, CEO of Global Healthcare Accreditation (GHA), known for its focus on medical travel. In this discussion, Stephano highlights how GHA’s accreditation enhances patient experiences and improves healthcare offerings worldwide. She explains GHA’s mission and how it helps healthcare organizations develop effective medical travel strategies.
Stephano outlines the ways GHA improves the patient journey, manages risks, and builds trust with international patients. She also shares success stories that showcase the measurable impacts of GHA’s guidance. Let’s explore her insights on GHA's transformative role in healthcare.
Who is GHA and what is your mission?
Global Healthcare Accreditation (GHA) was founded in 2016 with a clear vision: to establish best practices in medical travel that enhance quality, improve patient experience,
and mitigate risks across the entire care continuum. However, we see ourselves as more than just an accreditation body—we're strategic partners dedicated to advancing global healthcare practices.
Our team brings together expertise from top accreditation agencies, healthcare innovators, and seasoned medical travel executives. This unique blend of knowledge allows us to offer customized solutions for governments, healthcare organizations, and industry leaders worldwide.
Our mission extends beyond traditional boundaries, aiming to raise healthcare standards globally by bridging the gaps between medical tourism, healthcare services, hospitality, and wellness. We have also developed programs for key stakeholders in the medical travel industry, including physicians, facilitator agencies, hotels, and telehealth programs, to promote a safe and quality patient experience across all touch points.
We are proud to count among our
A SUCCESSFUL MEDICAL TRAVEL STRATEGY ISN’T JUST ABOUT MARKETING; IT REQUIRES INTEGRATION ACROSS ALL DEPARTMENTS, FROM ADMISSIONS TO DISCHARGE. GHA ASSISTS ORGANIZATIONS IN STREAMLINING THEIR PROCESSES TO HANDLE THE LOGISTICAL COMPLEXITIES OF MEDICAL TRAVEL, ENSURING THAT THE PATIENT JOURNEY IS SEAMLESS AT EVERY STAGE
accredited clients, some of the top hospital brands in the world, underscoring the value we bring to our clients.
Healthcare organizations partnering with GHA often see increased patient volumes and higher satisfaction scores. Moreover, our accreditation process and strategic guidance contribute to the overall enhancement of business strategies, positioning our partners at the forefront of the global healthcare market.
It's important to keep in mind that today’s traveling patients are more discerning than ever when considering their healthcare options. Global Healthcare Accreditation (GHA) sets the standard for organizations that are ready to build patient confidence and trust in their brand through the implementation and validation of best practices that prioritize quality, safety and patient experience.
What do you see as the primary benefits of accreditation to healthcare providers?
Accreditation, whether for general healthcare services or specialized areas like medical travel, provides numerous benefits to healthcare providers. It demonstrates a willingness to undergo rigorous evaluation by an independent third party, assessing compliance with recognized best practice standards. This process builds trust, enhances the organization's reputation, and strengthens patient confidence.
It also drives continuous quality improvement, enhances patient safety, and often leads to more efficient operations. For general healthcare, this can result in better clinical outcomes, reduced costs, and improved staff satisfaction. In the medical travel context, accreditation addresses the unique challenges of serving international patients, from cultural competence to continuity of care across borders.
By adhering to recognized standards in both general healthcare and medical travel, providers position themselves as leaders in quality and patient-centered care. This not only has the potential to attract more patients— both local and international—but also contributes to the overall advancement of healthcare practices globally.
Developing a successful medical travel strategy can be challenging. What unique insights and expertise does GHA bring to healthcare organizations looking to create or refine their programs?
GHA brings a wealth of expertise and specialized knowledge to help healthcare organizations develop robust medical travel strategies that are sustainable and patient-focused.
With extensive experience in medical travel, we offer healthcare organizations unique insights into market trends, patient expectations, and best practices. We leverage data, research, and our global network to help organizations understand which services to prioritize and how to attract international patients.
One of our key strengths is the ability to provide customized solutions. Every healthcare organization has its own set of strengths, weaknesses, and target markets. GHA works closely with organizations to develop a strategy that aligns with their specific goals—whether that means attracting patients from specific regions, offering specialized services, or improving operational efficiency.
A successful medical travel strategy isn’t just about marketing; it requires integration across all departments, from admissions to discharge. GHA assists organizations in streamlining their processes to handle the logistical complexities of medical travel, ensuring that the patient journey is seamless at every stage. Our holistic approach ensures that healthcare providers can build or refine their medical travel programs with confidence and measurable success.
Improving the patient experience is a critical aspect of medical travel. How do your programs specifically help healthcare organizations enhance the entire patient journey, from pre-arrival to post-treatment?
Improving the patient experience in medical travel goes beyond providing excellent clinical
ONE OF OUR KEY STRENGTHS IS THE ABILITY TO PROVIDE CUSTOMIZED SOLUTIONS. EVERY HEALTHCARE ORGANIZATION HAS ITS OWN SET OF STRENGTHS, WEAKNESSES, AND TARGET MARKETS. GHA WORKS CLOSELY WITH ORGANIZATIONS TO DEVELOP A STRATEGY THAT ALIGNS WITH THEIR SPECIFIC GOALS— WHETHER THAT MEANS ATTRACTING PATIENTS FROM SPECIFIC REGIONS, OFFERING SPECIALIZED SERVICES, OR IMPROVING OPERATIONAL EFFICIENCY
care; it's about ensuring a seamless journey from the moment a patient considers traveling for treatment to the time they return home. At Global Healthcare Accreditation, our programs are specifically designed to support healthcare organizations in enhancing this entire process.
Starting with the pre-arrival phase, we help organizations improve communication and transparency, which is crucial for building patient confidence, especially when they are traveling across borders. This involves guiding healthcare providers in creating clear, culturally sensitive, and multilingual communication strategies. These efforts ensure that patients fully understand their treatment options and have the necessary logistical support for things like visas, accommodations, and travel arrangements.
During the treatment phase, our focus shifts to ensuring that patients feel welcomed and supported within the healthcare facility. This includes not only clinical care but also the overall environment—everything from patient-centered hospitality to addressing any cultural or dietary needs. We help organizations implement processes that foster trust and comfort, ensuring that patients are not just treated but cared for in every sense.
Post-treatment, the patient’s journey continues. GHA assists healthcare organizations in establishing robust follow-up systems to ensure patients have access to necessary aftercare, whether that involves monitoring recovery remotely or coordinating with local physicians in their home country. By improving continuity of care, organizations can reduce the stress and uncertainty that can accompany posttreatment recovery, particularly for international patients. In short, our programs are designed to create a patient-centered experience that extends far beyond the medical procedure itself, ensuring healthcare organizations provide an experience that feels seamless, personalized, and reassuring at every step.
How does GHA help healthcare organizations identify and mitigate risks specific to medical travel patients that might be overlooked in standard healthcare processes?
Medical travel presents unique risks that are often not fully addressed in traditional healthcare processes. At GHA, we help organizations proactively identify and mitigate these risks to ensure patient safety and satisfaction. We guide healthcare organizations in addressing communication barriers and cultural differences, which can significantly affect patient safety. Language misunderstandings or differences in expectations can lead to treatment delays or errors. We help organizations develop strategies to bridge these gaps, including hiring multilingual staff and providing culturally competent care. Traveling patients face additional risks, such as complications from long-haul flights, jet lag, or unfamiliarity with local health systems. Our programs include guidance on mitigating these risks by ensuring facilities have comprehensive pre-travel risk assessments, medical travel insurance partnerships, and protocols for managing complications post-discharge when the patient is far from their home country.
International patients may carry infections from their home country or be exposed to different pathogens during travel. GHA helps healthcare organizations enhance their infection control practices and screen for potential risks that are unique to cross-border healthcare. By focusing on these oftenoverlooked risks, GHA accreditation ensures that healthcare organizations provide a higher standard of care for medical travel patients.
In terms of patient safety and quality, what are some key areas where GHA's accreditation makes a measurable impact for healthcare organizations? GHA accreditation makes a significant impact in several key areas that directly affect patient safety and quality. GHA emphasizes a focus on delivering personalized, culturally sensitive care. Accredited organizations are required to recognize and address the unique needs of medical travel patients, ensuring they feel understood, respected, and wellsupported throughout their treatment. We help healthcare providers adopt safety standards that meet the unique needs of
ONE OF THE MAIN CHALLENGES IN MEDICAL TRAVEL IS ENSURING CONTINUITY OF CARE ONCE THE PATIENT RETURNS HOME. GHA ENSURES THAT ORGANIZATIONS HAVE SYSTEMS IN PLACE FOR ROBUST POST-TREATMENT FOLLOW-UP, OFFERING REMOTE CONSULTATIONS AND PARTNERSHIPS WITH LOCAL HEALTHCARE PROVIDERS TO SUPPORT PATIENT RECOVERY.
medical travel patients. This includes tailored risk management strategies, pre-travel assessment, medication reconciliation across the medical travel care continuum, and enhanced communication protocols to avoid misunderstandings between providers and patients from diverse backgrounds.
One of the main challenges in medical travel is ensuring continuity of care once the patient returns home. GHA ensures that organizations have systems in place for robust post-treatment follow-up, offering remote consultations and partnerships with local healthcare providers to support patient recovery. By addressing these areas, GHA accreditation helps healthcare organizations create a safer, higher-quality care environment, which translates into better patient outcomes and improved organizational performance.
Medical travel involves many stakeholders beyond just hospitals. Can you explain how GHA supports various health and travel stakeholders, such as physicians, facilitators, and even hotels, in aligning for patient success?
Medical travel is a complex ecosystem that involves multiple stakeholders—hospitals, physicians, facilitators, hotels, and even local tourism agencies. GHA recognizes the need for collaboration across these sectors to ensure a safe and positive patient experience. Our programs are designed to be flexible and provide support at various stages of development, whether the organization is just starting to explore medical travel or looking to enhance existing services. This includes comprehensive training, coaching, and advisory services focused on areas like medical travel strategy, wellness, market identification, building strategic partnerships, implementing safety protocols, and improving the overall patient/guest experience.
For example, we provide guidance to healthcare organizations on how to involve physicians in the entire medical travel process. This includes pre-travel consultations, treatment coordination, and post-treatment follow-up. We also offer training and certification programs for physicians to and
staff to help them better understand the unique needs of international patients.
Medical travel facilitators play a crucial role in coordinating care. GHA offers accreditation and best practices for facilitators, ensuring they have the right systems in place to guide patients through the entire process—from initial inquiry to follow-up care. This ensures a smoother experience for the patient and a stronger partnership between facilitators and healthcare providers. Recognizing that medical travelers often need accommodation and recovery services, GHA helps organizations build partnerships with wellness facilities.
GHA’s WellHotel® Accreditation certifies hotels, resorts, and rental properties that provide holistic wellness experiences, including tiers for medical travelers and corporate wellness. These hotels earn the trusted WellHotel® seal through a comprehensive review and site inspection, validating their safety, cleanliness, and ability to meet cultural, dietary, and accessibility needs— enhancing patient/guest trust and experience.
Additionally, GHA’s Telehealth Accreditation program benchmarks excellence in telehealth, evaluating patient experience, care processes, and business practices. By accrediting telehealth services, GHA ensures that the same rigorous standards applied to in-person care also extend to digital health platforms, enhancing patient safety and continuity of care. By aligning these various stakeholders, GHA ensures a cohesive, patient-centered experience that leads to better outcomes and satisfaction for medical travel patients.
How do GHA's standards and accreditation programs help healthcare organizations not only attract international patients but also build trust with them throughout their healthcare journey?
GHA's standards and accreditation programs are specifically designed to help healthcare organizations attract international patients by creating a foundation of trust and reliability. By meeting GHA’s rigorous standards,
GHA’S WELLHOTEL® ACCREDITATION CERTIFIES HOTELS, RESORTS, AND RENTAL PROPERTIES THAT PROVIDE HOLISTIC WELLNESS EXPERIENCES, INCLUDING TIERS FOR MEDICAL TRAVELERS AND CORPORATE WELLNESS THESE HOTELS EARN THE TRUSTED WELLHOTEL® SEAL THROUGH A COMPREHENSIVE REVIEW AND SITE INSPECTION, VALIDATING THEIR SAFETY, CLEANLINESS, AND ABILITY TO MEET CULTURAL, DIETARY, AND ACCESSIBILITY NEEDS—ENHANCING PATIENT/GUEST TRUST AND EXPERIENCE.
organizations demonstrate their commitment to providing safe, high-quality care that caters to the unique needs of medical travel patients. This is crucial for patients who are traveling abroad for treatment and may have concerns about the quality of care, cultural differences, or language barriers. GHA accreditation helps build confidence right from the initial stages of inquiry, as patients can be assured that the facility has met international best practices. Additionally, our programs emphasize not just clinical quality but the entire patient experience—ensuring that healthcare providers are well-equipped to manage the logistics, communication, and aftercare needs of international patients. This comprehensive approach fosters trust throughout the entire healthcare journey, from the first point of contact to follow-up care after the patient has returned home.
Can you share any success stories where healthcare organizations improved their medical travel programs or patient outcomes by working with GHA? What measurable changes did they experience?
One of the most compelling aspects of GHA’s work is the tangible success stories from healthcare organizations that have worked with us to enhance their medical travel programs. For example, a hospital in the Middle East that sought to increase its international patient base worked closely with GHA to address several key areas. By adopting our accreditation standards, they improved communication protocols, trained staff to better handle cultural differences, and streamlined their logistics for international patients. Within the first year of accreditation, the hospital saw a 30% increase in international patient inquiries and a significant rise in patient satisfaction scores. Another success story comes from a Southeast Asian hospital that, after working with GHA, reduced its post-treatment complication rate by 15%, due to improved risk management strategies and better continuity of care protocols.
These measurable changes demonstrate how GHA’s programs lead to improved patient outcomes and organizational performance.
What sets GHA apart from other accreditation or consulting organizations in the medical travel space, particularly in terms of the depth of services you provide across the entire patient journey?
What sets GHA apart is our comprehensive, patient-centered approach that goes beyond clinical quality, encompassing every touchpoint of the medical travel journey.
However, we not only evaluate the quality and safety of healthcare services but also the key business areas that drive the success of medical travel programs—like marketing, financial transactions, and IT systems.
This ensures that the entire ecosystem supporting medical travel is optimized for both patient care and operational performance, which ultimately boosts the financial health of the program.
Additionally, GHA offers unmatched post-accreditation visibility and branding opportunities to elevate our clients' profiles in the global market. Through collaborations with Medical Tourism Magazine—the largest publication in the industry with a readership of over 2 million—we provide clients with strategic media exposure, including interviews and press releases that highlight their success. Our globally recognized seal of accreditation is not just a mark of quality but also serves as a powerful branding tool that enhances trust and credibility among international patients, payers, and stakeholders.
At GHA, we measure our success through the achievements and success of our clients. We strive to be a strategic partner, working closely with healthcare organizations and other stakeholders to ensure their medical travel programs are not only aligned with the highest standards but are also positioned for long-term growth, visibility, and market leadership. This unique combination of holistic evaluation, expert guidance, and global visibility truly sets GHA apart in the medical travel space.
THROUGH COLLABORATIONS WITH MEDICAL TOURISM MAGAZINE— THE LARGEST PUBLICATION IN THE INDUSTRY WITH A READERSHIP OF OVER 2 MILLION— WE PROVIDE CLIENTS WITH STRATEGIC MEDIA EXPOSURE, INCLUDING INTERVIEWS AND PRESS RELEASES THAT HIGHLIGHT THEIR SUCCESS. OUR GLOBALLY RECOGNIZED SEAL OF ACCREDITATION IS NOT JUST A MARK OF QUALITY BUT ALSO SERVES AS A POWERFUL BRANDING TOOL THAT ENHANCES TRUST AND CREDIBILITY AMONG INTERNATIONAL PATIENTS, PAYERS, AND STAKEHOLDERS
The Delicate Balance of Patient Advocacy: Who Truly Has the
Patient’s Best Interest in Mind?
Ali Elhaj, LLM., Ph. D. Chief Executive Officer at Ardens Health
In today’s complex healthcare landscape, patients often find themselves navigating a labyrinth of decisions made by various healthcare providers. While the ideal scenario would be a seamless system where all healthcare decisions are driven solely by the patient’s best interests, the reality is more nuanced. Patients often wonder: Are their interests genuinely at the forefront of their provider’s mind, or are these interests sometimes sidelined by external factors, including economic pressures, ethical dilemmas, medicolegal issues, and the personal integrity of their healthcare providers?
Trust at Its Core
The cornerstone of any successful healthcare journey is the provider-patient relationship, which is built on trust, communication, and shared decision-making. Ideally, this relationship should be guided by the principle of “do no harm,” with healthcare providers acting as patient advocates committed to delivering the best possible care. Ethical and moral integrity in healthcare professionals is crucial; when providers uphold these values, they serve as staunch defenders of their patients’ rights and well-being. The principles of medical ethics— autonomy, beneficence, non-maleficence, and justice—are essential in ensuring that patient care remains compassionate and equitable. However, when providers fall short of these ethical standards, patients may find themselves at a significant disadvantage. Despite the presence of regulatory bodies, accreditation standards, medicolegal protections, and a myriad of policies designed to protect patients, these measures alone cannot guarantee patient-centered care. The moral compass of individual providers plays a pivotal role, and when it deviates, patient advocacy often falters. Medical ethics and medicolegal issues intersect when providers face dilemmas,
such as balancing patient autonomy with professional judgment or navigating conflicts of interest that could compromise care.
Economic Pressures: Hidden Influencer of Clinical Decisions
Economic factors significantly impact healthcare delivery, often subtly influencing clinical decisions. Providers operate within a system where financial incentives, insurance constraints, and resource limitations can affect their choices. For instance, the push
ETHICAL GUIDELINES OFTEN EMPHASIZE PATIENT AUTONOMY AND INFORMED CONSENT, WHICH ARE CRITICAL COMPONENTS OF MEDICOLEGAL PROTECTION.
for cost-effective care might lead to undertreatment, delayed procedures, or the preference for less expensive but potentially less effective treatment options. These decisions, while framed within the context of economic sustainability, can directly conflict with the optimal interests of the patient and raise medicolegal concerns, particularly when financial motives influence the quality of care.
In such scenarios, even the most wellintentioned providers may face a moral and legal quandary: balancing the need to manage limited resources with their duty to provide the highest standard of care. When economic pressures outweigh clinical judgment, the patient’s needs can become secondary, leaving them vulnerable to compromised care. From a medicolegal perspective, this situation can lead to breaches in the standard of care, exposing providers to potential malpractice claims and legal repercussions.
Ethical and Regulatory Safeguards: Necessary but Not Sufficient
Healthcare is highly regulated, with a plethora of guidelines, ethical codes, and medicolegal frameworks designed to protect patients. Regulatory bodies, such as state medical boards, accreditation organizations, and professional associations, establish standards intended to prevent malpractice and ensure quality care. However, these safeguards, while essential, are not foolproof. They cannot fully insulate patients from providers who may lack the ethical grounding to make decisions in the patient’s best interest.
Moreover, ethical guidelines often emphasize patient autonomy and informed consent, which are critical components of medicolegal protection. When these principles are not respected, patients’ rights are compromised, leading to legal implications for providers. Patients often lack the knowledge or confidence to challenge their provider’s recommendations, especially in a system where medical jargon and complex protocols create a significant barrier to understanding. This power imbalance can leave patients feeling disempowered and reluctant to advocate for themselves, particularly when they sense that
economic considerations and legal complexities are overshadowing their care.
The Role of Patient Advocacy: Empowering the Vulnerable
Patient advocacy is a critical component of modern healthcare, serving as a vital bridge between patients and providers. Advocates help patients navigate the healthcare system, understand their rights, and ensure that their voices are heard in clinical decision-making. By empowering patients, advocates can counterbalance some of the economic, ethical, and medicolegal pressures that threaten patient-centered care. Healthcare organizations must prioritize patient advocacy by training staff, implementing clear communication channels, and fostering an environment where patients feel supported and heard. Additionally, providers must remain vigilant in examining their own biases and motivations, continually striving to uphold the ethical, legal, and moral standards that the profession demands. When ethical and medicolegal principles align, patient care is not only improved but also protected from potential legal disputes.
Protecting Patient Interests in a Complex System
Ultimately, the protection of patient interests hinges on a delicate interplay between provider integrity, systemic safeguards, medical ethics, medicolegal accountability, and effective patient advocacy. While regulatory frameworks and ethical guidelines provide a necessary foundation, the real test lies in the everyday decisions made by individual providers. Patients deserve a healthcare experience that places their well-being at the forefront, free from the undue influence of economic considerations, compromised ethical standards, or legal uncertainties. For patients to truly have their interests protected, healthcare systems must champion transparency, uphold ethical and legal accountability, and prioritize patient advocacy at every level. Only then can we ensure that the healthcare system serves as a true guardian of patient rights, delivering care that is compassionate, equitable, and unwavering in its commitment to the patient’s best interest.
FOR PATIENTS TO TRULY HAVE THEIR INTERESTS PROTECTED, HEALTHCARE SYSTEMS MUST CHAMPION TRANSPARENCY, UPHOLD ETHICAL AND LEGAL ACCOUNTABILITY, AND PRIORITIZE PATIENT ADVOCACY AT EVERY LEVEL. ONLY THEN CAN WE ENSURE THAT THE HEALTHCARE SYSTEM SERVES AS A TRUE GUARDIAN OF PATIENT RIGHTS, DELIVERING CARE THAT IS COMPASSIONATE, EQUITABLE, AND UNWAVERING IN ITS COMMITMENT TO THE PATIENT’S BEST INTEREST.
Dr. Ali Elhaj
Electronic Cigarettes: A Modern Trend
Dr. Fathi Abdulqader, Internal medicine Consultant at Al-Ahli Hospital/Qatar
An electronic cigarette is a device that converts liquid into aerosol, producing fine particles that can be inhaled like traditional tobacco smoking. As people became more aware of the harms of smoking, efforts were made to find ways to quit or reduce smoking. The electronic cigarette emerged as one of these methods.
Components of Electronic Cigarettes
Electronic cigarettes consist of the following parts:
• Mouthpiece: A tube to assist in inhaling the aerosol.
• Tank: A container for the smoking liquid.
• Liquid solution: The substance intended for inhalation, placed in the tank.
• Battery: The power source.
• Heating coil: The component responsible for heating the liquid.
• Power button: Found on some electronic cigarette models.
• Light source: Located at the tip of some models to simulate combustion.
How Electronic Cigarettes Work?
The modern functioning of electronic cigarettes primarily depends on a device known as the"cartomizer", which was developed in 2006. The cartomizer consists of an electronic coil wrapped around a silica wick inside a small tank filled with the liquid to be inhaled, such as nicotine or other flavored substances. The tank, connected to an external vent, has a flexible valve powered by a battery with a voltage of 3 to 6 volts. When activated during inhalation, the coil heats the liquid to a temperature of 200°C, turning it into vapor or aerosol, which can be inhaled into the lungs, simulating the act of smoking traditional tobacco cigarettes. Some models include a red light at the tip to mimic the appearance of burning tobacco.
What Substances Are Produced by Smoking an Electronic Cigarette?
The substances produced by smoking an electronic cigarette vary depending on the type of liquid used, the temperature of vaporization, and the materials used to manufacture the heating element. In addition to the smoking liquid and solvent, by-products such as tetraamines, aldehydes, various metals like cadmium and zinc, and over 80 different chemical compounds, some of which may be carcinogenic, are produced.
Why Do People Use Electronic Cigarettes?
• The appeal of electronic cigarettes lies in several factors:
• They mimic the act of traditional smoking and can help reduce or quit smoking.
• Users can choose from a variety of flavors,
CONSISTS OF AN ELECTRONIC COIL WRAPPED AROUND A SILICA WICK INSIDE A SMALL TANK FILLED WITH THE LIQUID TO BE INHALED, SUCH AS NICOTINE OR OTHER FLAVORED SUBSTANCES.
making them more enjoyable.
• The perception is that they are less harmful than traditional cigarettes.
• They are seen as a modern alternative to smoking.
• They serve as a substitute for smoking in nosmoking areas.
• Belief in the safety of pregnant women.
• They are less costly.
• They leave less odor on clothing and breath compared to traditional smoking.
Side Effects of Electronic Cigarettes
• Throat and pharynx irritation.
• Nausea, vomiting, and stomach pain.
• Increased risk of heart disease.
• Birth defects in pregnant women.
• Potential use for inhaling harmful substances.
• Risk of addiction.
• Withdrawal symptoms upon cessation.
• Fire or overheating of the heating coil.
Health Issues Linked to Electronic Cigarettes
With the growing use of electronic cigarettes, several health concerns have emerged, including:
• Respiratory infections, particularly those linked to electronic cigarette use.
• Poisoning from the ingestion of electronic
cigarette liquids, either by children or in cases of adult suicide attempts.
• Explosions or fires caused by electronic cigarettes lead to injuries such as facial or eye damage.
Are Electronic Cigarettes Safe?
Studies have shown that using electronic cigarettes is generally safer than smoking traditional cigarettes and less harmful to overall health. However, they are less effective in helping smokers quit compared to other methods like nicotine gum or patches. Furthermore, when used alongside traditional cigarettes, they do not significantly reduce the risk of mortality. Statistics indicate that the largest group of electronic cigarette users are young people and school students, accounting for 13% of users, while older adults make up 10%. Usage is increasing, and in 2016, regulations were introduced in the European Union to control their use and limit advertising. It is important to correct misconceptions about electronic cigarettes and increase public awareness of their potential harm to reduce their usage for the benefit of all.
IT IS IMPORTANT TO CORRECT MISCONCEPTIONS ABOUT ELECTRONIC CIGARETTES AND INCREASE PUBLIC AWARENESS OF THEIR POTENTIAL HARM TO REDUCE THEIR USAGE FOR THE BENEFIT OF ALL.
New Smart Hospital Bed Could Massage and Bathe Patients
Apatent has been granted for a smart hospital bed that offers a number of automated features, including massage and self-cleaning systems. If brought to market, this bed could help alleviate the burden on healthcare systems and improve patient care.
Technological innovations are constantly improving healthcare in the United States and around the world. Now, a patent has been granted for a new invention that could help ease the burden on overworked healthcare workers in hospital settings and improve patient care in the future.
The patent, filed by Jiangsu Jinsu Medical Technology Co., Ltd. in 2019 and granted in 2024, is for a “smart hospital bed” that offers many automated services that are typically performed by a human caregiver.
This includes an integrated massage system, a cooling and drying system, automatic mattress replacement, an integrated bathing system, and wastewater management.
“There is an extreme shortage of nurses, caregivers at patients’ bedsides, and the nurseto-patient ratio keeps getting higher in hospital systems around the world,” says Archita Sivakumar Fritz, a professional in the MedTech and Life Sciences industry whose expertise extends from research and development to quality systems management and marketing.
Fritz worked for 16 years at Stryker, a company that makes intelligent hospital beds. She says a bed like the one described in the patent grant could really help ease the burden on healthcare systems and provide much-needed care to patients in their time of need.
How it compares to intelligent hospital beds on the market
Several intelligent beds are currently available on the market from companies including HillRom, Stryker, Linet, and Paramount. These hospital beds allow the caregiver to set certain features, such as patient fall risk, bed location
TECHNOLOGICAL INNOVATIONS ARE CONSTANTLY IMPROVING HEALTHCARE IN THE UNITED STATES AND AROUND THE WORLD. NOW, A PATENT HAS BEEN GRANTED FOR A NEW INVENTION THAT COULD HELP EASE THE BURDEN ON OVERWORKED HEALTHCARE WORKERS IN HOSPITAL SETTINGS AND IMPROVE PATIENT CARE IN THE FUTURE.
services, autonomous mattress turning to reduce the potential for bed-related pressure ulcers, an in-bed weighing function, and more.
Fritz says these beds are not new, with many having been on the market for almost two decades. They were initially only used in ICU and critical care spaces but were eventually more widely adopted in medical-surgical units.
“Based on the patent information provided, this ‘Intelligent Hospital Bed’ by Jiangsu Jinsu Medical Technology Co., Ltd. offers several innovative features that differentiate it from typical acute care and ICU beds produced by companies like Stryker, Hill-Rom, and Linet,” Fritz tells Healthnews.
The first feature that sets this bed apart from others on the market is the automated massage mechanism, which uses adjustable components and rollers to move bed boards up and down. This feature aims to prevent muscle atrophy and improve circulation for long-term patients, which Fritz says is not commonly found in standard ICU beds
“Usually, you see this in the mattress that goes on the bed which provides patient turning capabilities,” she says. “The fact that it is physically in the structure of the bed is interesting.”
Next is the cooling and drying system, which aims to keep the patient at a comfortable temperature. To do this, the bed incorporates ventilation holes with fans to cool and dry the patient's skin, as well as heating elements. While most mattress manufacturers in the acute care and ICU bed category do have a function to help prevent bedsores, Fritz says most do not have a heating element, which may be beneficial for certain types of patients and conditions. A particularly unique feature of this bed is its automatic mattress replacement mechanism. Using a series of rollers and gears, the bed features a system that can change its mattress automatically. Typically, changing mattresses requires a significant amount of manual labor and is a major cause of caregiver injuries, Fritz says, so this could help alleviate
that issue. The bed also includes a water spray mechanism with multiple nozzles, allowing patients to be bathed in place. Fritz says some advanced ICU beds do offer basic cleaning features, but a full bathing system is not typically found in hospital beds.
“This is another big benefit and differentiation of the bed,” she says. “Being able to not transfer a patient, especially those that are critical, is a big benefit to help eliminate potential patient falls, manual handling injuries, and hospital acquired infections.”
The bed also incorporates a wastewater management system. The system collects and separates liquid and solid waste to improve hygiene, which Fritz says would provide a significant benefit.
What it could mean for the healthcare system
This smart bed could benefit caregivers and patients alike, including reduced manual labor, improved patient comfort, enhanced hygiene, and more comprehensive care.
If it were to become available on the market in the future, this bed could potentially address a number of issues and improve care in hospitals. However, the granted patent lacks several explanations for how these systems actually function.
Fritz says it’s difficult to assess how the automatic mattress replacement function works based on the information in the application. For the integrated bathing system, she notes that the patent grant does not mention some very basic testing requirements needed for such a bed, such as an IPX6 cleaning rating. The same is true for the wastewater management system, with regulatory and quality requirements associated with a bed like this missing.
“It's important to note that while these features are innovative, the bed's practical implementation, durability, ease of use, and compatibility with existing hospital systems would need to be evaluated,” Fritz says. “Additionally, the cost, quality, testing and maintenance requirements of such a complex system could be potential drawbacks.”
A PARTICULARLY UNIQUE FEATURE OF THIS BED IS ITS AUTOMATIC MATTRESS REPLACEMENT MECHANISM. USING A SERIES OF ROLLERS AND GEARS, THE BED FEATURES A SYSTEM THAT CAN CHANGE ITS MATTRESS AUTOMATICALLY. TYPICALLY, CHANGING MATTRESSES REQUIRES A SIGNIFICANT AMOUNT OF MANUAL LABOR AND IS A MAJOR CAUSE OF CAREGIVER INJURIES, FRITZ SAYS, SO THIS COULD HELP ALLEVIATE THAT ISSUE.
Transforming the Operating Room: New Era in Surgical Care
Operating rooms have seen significant advancements in tools, technologies, and innovations that have improved surgical outcomes and enhanced team efficiency. These developments contribute to more precise procedures, reduced surgical risks, and quicker patient recovery. Today, highly precise tools like surgical robots and advanced endoscopes allow for more accurate procedures with minimized risks. New anaesthesia techniques have also been developed, making the process safer and more effective. New technologies allow real-time patient monitoring during surgeries, enhancing safety and recovery. Innovations in pain management have improved patient comfort and outcomes, while also increasing procedural accuracy and reducing risks. These advancements enable medical teams to perform more surgeries efficiently. As surgical technology continues to evolve, we can expect further innovations that will enhance patient care and team efficiency.
Digital Technology in Operating Rooms
In recent decades, operating rooms have evolved into fully integrated digital environments, improving healthcare quality and enhancing surgical precision. Today’s digital operating rooms connect devices through a single system, allowing real-time data collection and analysis, which aids surgeons in making accurate decisions during procedures. Modern operating rooms also feature high-definition displays, enabling surgeons to access patient information directly during surgery. This technology boosts quick decision-making, streamlines workflow, and ultimately benefits patient health.
Live Imaging
Modern technology now enables surgeries to be broadcast live to medical conferences, facilitating knowledge exchange among physicians worldwide. Live imaging in operating rooms uses various imaging techniques, such
as X-rays, MRI, and CT scans, directly within the surgical setting. These real-time, detailed images of tissues and organs help surgeons make precise decisions and reduce the risk of errors.
Surgical Robotics
Robotic systems have revolutionized surgical procedures, offering high precision and 3D visualization that allows surgeons to access hard-to-reach areas without large incisions. This type of surgery minimizes pain and speeds recovery. Robotic surgery has transformed the field by enabling surgeons to perform complex procedures with unmatched accuracy and effectiveness.
Robotic systems provide extremely precise movements, giving surgeons greater flexibility and a clear 3D view of the surgical site. Smaller incisions reduce pain and bleeding, allowing faster recovery than traditional open surgery.
Remote Control
Surgeons can control robotic systems remotely through a control unit, enabling them to perform intricate procedures with high precision. This remote-control technology allows surgeons to operate from a distance, using high-resolution 3D screens for a clear view of the surgical area. Significant advancements are expected in this field, including more sophisticated robotics and faster, more reliable communication systems. Innovations in virtual reality are also underway, promising a more immersive experience for surgeons.
Minimally Invasive Tools
Laparoscopic Surgery
Laparoscopic techniques have evolved significantly, with smaller, more efficient tools allowing surgeries to be performed with minimal invasiveness, reducing recovery times and infection risks. This technique provides surgeons with a clear view of internal organs on a large screen, enabling complex surgeries with high precision and less tissue disruption.
ROBOTIC SYSTEMS HAVE REVOLUTIONIZED SURGICAL PROCEDURES, OFFERING HIGH PRECISION AND 3D VISUALIZATION THAT ALLOWS SURGEONS TO ACCESS HARDTO-REACH AREAS WITHOUT LARGE INCISIONS. THIS TYPE OF SURGERY MINIMIZES PAIN AND SPEEDS RECOVERY. ROBOTIC SURGERY HAS TRANSFORMED THE FIELD BY ENABLING SURGEONS TO PERFORM COMPLEX PROCEDURES WITH UNMATCHED ACCURACY AND EFFECTIVENESS.
Laparoscopic surgery has been revolutionary for both patients and surgeons. As technology continues to develop, laparoscopic surgery is expected to become the preferred method for many procedures.
Single-Use Instruments
There is a growing trend toward single-use surgical tools, which enhances sterilization standards and reduces infection risk. Designed for one-time use and disposal, these tools play a key role in patient safety by significantly reducing the chance of cross-infection. The demand for single-use instruments is expected to increase, with research focused on developing more efficient materials and environmentally friendly solutions, such as recyclable plastics. The use of single-use tools is critical for minimizing infection risks, avoiding tool re-sterilization, reducing contamination, and safeguarding patient health.
Advanced Imaging Technologies
Interventional Imaging
Advancements in surgery have integrated interventional imaging techniques into operating rooms, significantly enhancing procedures. Surgeons now have access to high-resolution 3D views of organs and tissues, allowing for more precise decision-making. With technologies like CT and MRI, real-time images of internal structures can be obtained during operations. These systems connect to computers that display the images on large screens, enabling surgeons to visualize the body while they work.
Hybrid Operating Rooms
Hybrid operating rooms combine traditional surgical techniques with interventional imaging to create a flexible environment for a wide range of complex surgical procedures. Equipped with cutting-edge medical technology, including diagnostic imaging systems such as X-ray, MRI, and CT, hybrid rooms allow surgeons to view 3D images of organs and tissues in real time, enhancing precision and effectiveness in treatment decisions.
These rooms offer high-definition 3D images, reducing traditional surgical risks like bleeding and infection by enabling precise planning and execution. They reduce surgical time, improve outcomes, and make previously impossible procedures possible, such as complex cardiovascular and cancer surgeries.
Improving the Surgical Environment
Advanced Lighting
Lighting is essential in operating rooms, not only enhancing visibility but also creating a comfortable, safe work environment. Significant improvements in surgical lighting have been made in recent years, enhancing surgical performance and efficiency. Optimized lighting systems in operating rooms provide ideal illumination, enabling medical teams to see intricate details during surgery. Good lighting provides clear visibility of tissues and organs, helping surgeons identify sensitive areas and avoid errors. It also reduces eye strain for the medical team, enhancing focus and reducing mistakes. In procedures that require magnification, like microsurgeries, lighting plays a critical role in improving image quality. Proper lighting creates a comfortable environment for the surgical team, increasing productivity.
Ventilation and Sterilization Systems
Operating rooms have seen significant advancements in ventilation and sterilization systems to ensure a safe, contaminant-free environment, reduce surgical infection risks, and improve surgical outcomes. Advanced ventilation systems maintain air quality, reducing infection risk and providing a secure setting for surgery.
These systems filter out particles, bacteria, viruses, and fungi from the air, helping to prevent infections among patients and healthcare workers. They provide clean, cool, and humidified air for a comfortable environment in operating rooms. Modern ventilation and sterilization systems are crucial for ensuring safe and efficient surgeries, and we can expect further innovations in this area.
OPERATING ROOMS HAVE SEEN SIGNIFICANT ADVANCEMENTS IN VENTILATION AND STERILIZATION SYSTEMS TO ENSURE A SAFE, CONTAMINANT-FREE ENVIRONMENT, REDUCE SURGICAL INFECTION RISKS, AND IMPROVE SURGICAL OUTCOMES. ADVANCED VENTILATION SYSTEMS MAINTAIN AIR QUALITY, REDUCING INFECTION RISK AND PROVIDING A SECURE SETTING FOR SURGERY
A New International Healthcare Sustainability Certification
Are you a healthcare organization accelerating your sustainable practices and seeking formal recognition?
Discover how Joint Commission International (JCI) and the Geneva Sustainable Centre (GSC) can support you on your journey toward sustainable healthcare.
